Other nutritional deficiencies

E4_NUTRIDEF

nutritional disorder: Any condition related to a disturbance between proper intake and utilization of nourishment.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E50-E64, E65-E68 Cause of death: ICD-10 — E50-E64, E65-E68 2 out of 7 registries used, show all original rules.	36699
4. Check minimum number of events None	36699
5. Include endpoints E4_VIT_DEF E4_CA_DEF E4_SELE_DEF E4_ZINC_DEF E4_COPP_DEF E4_FE_DEF E4_MG_DEF E4_MANG_DEF E4_CHRO_DEF E4_MOLYB_DEF E4_VANA_DEF E4_MULTI_DEF E4_NUTRIEL_NAS_DEF E4_FAT_DEF E4_IMBAL_FOOD E4_NUTRI_DEF_NAS E4_SEQUMAL	37331
6. Filter based on genotype QC (FinnGen only)	35975

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	E4_NUTRIDEF
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_VIT_DEF\|E4_CA_DEF\|E4_SELE_DEF\|E4_ZINC_DEF\|E4_COPP_DEF\|E4_FE_DEF\|E4_MG_DEF\|E4_MANG_DEF\|E4_CHRO_DEF\|E4_MOLYB_DEF\|E4_VANA_DEF\|E4_MULTI_DEF\|E4_NUTRIEL_NAS_DEF\|E4_FAT_DEF\|E4_IMBAL_FOOD\|E4_NUTRI_DEF_NAS\|E4_SEQUMAL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E[5-6]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E[5-6]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other nutritional deficiencies based on the number of shared cases.

Similar with more cases:

Endocrine, nutritional and metabolic diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	35975	24111	11864
Unadjusted period prevalence (%)	7.52	8.55	5.44
Median age at first event (years)	51.30	48.48	57.03

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
37331: Matched controls
351371

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

323.3

4767

25222

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.7

322.5

1871

6768

SGA01

NOMESCO Finland

Emergency treatment

1.8

322.4

6421

37224

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

321.4

17466

128831

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

319.7

6837

40426

M03BX02

ATC

tizanidine; oral

1.5

318.3

22807

178161

N03AX09

ATC

lamotrigine; oral

2.5

317.5

2174

8523

SPAT1301

SPAT

No procedures

1.6

315.4

10690

70994

J46

ICD-10 Finland

Status asthmaticus

3.3

311.3

1215

3513

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

310.8

2770

12186

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

309.2

9256

59628

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.4

307.7

5300

22366

R60.0

ICD-10 Finland

Localized oedema

2.5

307.7

4769

19758

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.5

307.7

5460

12876

H02AB06

ATC

prednisolone; systemic

1.8

307.7

17871

117808

E66

ICD-10 Finland

Obesity

12.3

307.7

6290

5712

R02

ICPC

Shortness of breath/dyspnoea

2.2

307.7

5060

23194

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

10.1

307.7

409

386

B01AA03

ATC

warfarin; systemic

1.9

307.7

5145

26832

R03BA05

ATC

fluticasone; inhalant

1.8

307.7

6931

39202

C03DA01

ATC

spironolactone; oral

2.9

307.7

4846

17231

C09AA02

ATC

enalapril; systemic

2.1

307.7

6297

31068

A10AE05

ATC

insulin detemir; parenteral

3.2

307.7

2417

7354

ZXD05

NOMESCO Finland

Urgent procedure

1.6

307.7

10768

71251

OAB72

NOMESCO Finland

Weight control and weight loss guidance

24.9

307.7

968

376

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

6511

35789

A10BJ06

ATC

semaglutide; parenteral

8.4

307.7

4260

5333

SPAT1240

SPAT

Therapeutic discussion

2.0

307.7

4536

23105

G47.3

ICD-10 Finland

Sleep apnoea

5.3

307.7

15582

41841

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

307.7

9878

63182

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

307.7

3886

17316

E66.1

ICD-10 Finland

Drug-induced obesity

88.5

307.7

391

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

307.7

7760

44145

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

307.7

7348

39200

A10AC01

ATC

insulin (human); parenteral

3.3

307.7

3440

10606

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

20703

154930

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

9791

60960

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.5

307.7

922

1988

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.3

307.7

1354

4007

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

307.7

6853

38324

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.5

307.7

1564

4328

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.7

307.7

5118

19221

N05AH04

ATC

quetiapine; oral

2.1

307.7

7553

37876

P76

ICPC

Depressive disorder

2.3

307.7

2993

12715

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

307.7

3499

16041

J01AA02

ATC

doxycycline; systemic

1.7

307.7

27955

222685

J01FA06

ATC

roxithromycin; oral

1.5

307.7

13823

96802

T90

ICPC

Diabetes non-insulin dependent

3.8

307.7

12322

40329

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.3

307.7

1210

2720

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

307.7

2801

11509

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.8

307.7

794

1577

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

307.7

4373

20851

A08AB01

ATC

orlistat; oral

21.8

307.7

651

286

N02BE01

ATC

paracetamol; systemic, rectal

2.7

307.7

33806

273687

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.7

307.7

2008

7304

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1461.5

307.7

890

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

27303

211511

J01MA12

ATC

levofloxacin; systemic

1.8

307.7

6119

34212

N03AX16

ATC

[U] pregabalin

2.0

307.7

8978

48267

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

307.7

4085

19735

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

10648

63811

A10BD07

ATC

metformin and sitagliptin; systemic

3.3

307.7

1756

5114

R03BA02

ATC

budesonide; inhalant

1.8

307.7

6576

37688

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

307.7

3542

16580

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.0

307.7

13343

43319

358

Kela drug reimbursment

liraglutide

16.1

307.7

422

250

3055, ,

Kela drug reimbursment

13.8

307.7

437

301

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

307.7

7317

42897

R03DC03

ATC

montelukast; oral

1.8

307.7

6287

35871

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

307.7

4307

19343

A10BH05

ATC

linagliptin; oral

3.5

307.7

1937

5388

R4190

NOMESCO Finland

Nutritional therapy

5.5

307.7

2590

4732

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

307.7

4471

19803

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.1

307.7

5551

26918

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

22.7

307.7

663

280

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.1

307.7

1485

2838

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

307.7

11159

67209

A28

ICPC

Limited function/disability NOS

1.9

307.7

4626

24113

103

Kela drug reimbursment

Diabetes, insulin-treated

4.0

307.7

13989

46081

S18

ICPC

Laceration/cut

1.6

307.7

15654

108344

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2890.7

307.7

3098

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

6.4

307.7

709

1068

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

8776

50351

C03AA03

ATC

hydrochlorothiazide; oral

2.6

307.7

3180

11940

SPAT1254

SPAT

Administration of medicine

1.9

307.7

5115

26520

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.2

307.7

3477

15713

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

11899

78704

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

307.7

7416

38151

R03BB04

ATC

tiotropium bromide; inhalant

2.3

307.7

3386

14329

N06AX12

ATC

bupropion; oral

2.5

307.7

3502

13965

SPAT1310

SPAT

Counselling related to known health issue

1.7

307.7

11597

75088

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

307.7

3074

11904

A10BK03

ATC

empagliflozin; oral

3.9

307.7

5048

13547

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.2

307.7

3927

18074

R5140

NOMESCO Finland

Monitoring the use of the aid

4.6

307.7

6920

16596

B01AB05

ATC

enoxaparin; parenteral

2.2

307.7

12798

66385

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

6108

27549

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

307.7

11798

59440

QBJ30

NOMESCO Finland

Correction of abdominal apron

32.6

307.7

1064

316

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

19292

144799

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

20.1

307.7

1080

521

E66.00

ICD-10 Finland

Metabolic syndrome

42.5

307.7

9640

2852

WX780

NOMESCO Finland

Remote monitoring CPAP

3.6

307.7

2147

5928

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

16335

107603

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

11441

74915

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

17096

112983

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

307.7

7543

44748

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

4.6

307.7

1228

2579

OAB72, ,

SPAT

7.0

307.7

818

1117

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.2

307.7

3528

15578

N05BA04

ATC

oxazepam; oral

1.7

307.7

9399

58215

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

419.5

307.7

1661

J96.1

ICD-10 Finland

Chronic respiratory failure

6.2

307.7

965

1508

A08AA02

ATC

fenfluramine; oral

7.4

307.7

501

647

J01DA01

ATC

[U] cefalexin

1.6

307.7

22580

169590

E61.1

ICD-10 Finland

Iron deficiency

4.6

307.7

1581

3323

C09DA01

ATC

losartan and diuretics; oral

2.1

307.7

3527

16711

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.0

307.7

3938

5797

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.2

307.7

5068

23571

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

307.7

5629

30460

205

Kela drug reimbursment

Chronic hypertension

2.6

307.7

9598

41915

N06AB10

ATC

escitalopram; oral

1.8

307.7

8399

49581

I50.0

ICD-10 Finland

Congestive heart failure

3.3

307.7

2283

6885

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

307.7

2010

7496

P01AB01

ATC

metronidazole; oral, rectal

1.6

307.7

14651

102711

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

16124

104349

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

5.5

307.7

2629

4753

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

307.7

8165

49508

C08CA01

ATC

amlodipine; oral

2.0

307.7

12865

74226

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.1

307.7

998

1880

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.6

307.7

5647

22199

E66.01

ICD-10 Finland

Obesity due to excess calories

97.4

307.7

20328

4261

M10.9

ICD-10 Finland

Gout, unspecified

3.1

307.7

2589

8208

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

307.7

6581

37947

XCK10

NOMESCO Finland

Photography of fundus of eye

2.3

307.7

3339

14455

E65

ICD-10 Finland

Localized adiposity

38.2

307.7

226

C02AC05

ATC

moxonidine; oral

3.3

307.7

1753

5209

E11

ICD-10 Finland

Type 2 diabetes mellitus

3.7

307.7

8087

24304

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

16561

102788

A10BX07

ATC

[U] liraglutide

17.7

307.7

1185

650

A08

ICPC

Swelling

3.0

307.7

1939

6237

3051, ,

Kela drug reimbursment

12.0

307.7

917

738

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.1

307.7

7671

38270

A10AE04

ATC

insulin glargine; parenteral

3.6

307.7

4903

14053

R06.5

ICD-10 Finland

Mouth breathing

2.3

307.7

3597

15661

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

307.7

3290

15022

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.3

307.7

4497

19525

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.5

307.7

1578

4319

A10AB05

ATC

insulin aspart; parenteral

3.1

307.7

3515

11328

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

307.7

4836

20062

A08AA62

ATC

bupropion and naltrexone; systemic

13.7

307.7

466

325

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.6

307.7

13224

37185

L15

ICPC

Knee symptom/complaint

1.8

307.7

8808

50733

C10AA01

ATC

simvastatin; oral

1.7

307.7

12366

77939

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.2

307.7

5323

6266

A10BK01

ATC

dapagliflozin; oral

3.7

307.7

3495

9524

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

307.7

2707

10453

E66.0

ICD-10 Finland

Obesity due to excess calories

476.3

307.7

1691

B81

ICPC

Anaemia vit B12/folate deficiency

3.9

307.7

1560

3904

C08CA13

ATC

lercanidipine; oral

2.1

307.7

4742

22775

N06AX16

ATC

venlafaxine; oral

2.3

307.7

6580

30489

T82

ICPC

Obesity

12.5

307.7

4799

4097

J45

ICD-10 Finland

Asthma

2.1

307.7

4071

19735

J01DB01

ATC

cefalexin; oral

2.2

307.7

31770

253443

A10BJ02

ATC

liraglutide; parenteral

12.9

307.7

2927

2297

M04AA01

ATC

allopurinol; systemic

3.1

307.7

5083

17200

N06AX11

ATC

mirtazapine; oral

1.6

307.7

12121

81333

A10BG03

ATC

pioglitazone; oral

5.3

307.7

1251

2278

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

307.7

5725

28287

N06AX21

ATC

duloxetine; oral

2.3

307.7

5215

22756

L03

ICPC

Low back symptom/complaint

1.7

307.7

10350

64804

N03AX12

ATC

[U] gabapentin; oral

2.0

307.7

6067

31764

SPAT1262

SPAT

Handing over of treatment supplies

3.1

307.7

8389

29841

EBA00

NOMESCO Finland

Extraction of tooth

1.6

307.7

13215

89191

P06

ICPC

Sleep disturbance

2.0

307.7

4822

24124

C07AB07

ATC

bisoprolol; oral

2.0

307.7

16793

102381

J01FF01

ATC

clindamycin; systemic

2.0

307.7

10811

60629

WX723

NOMESCO Finland

CPAP therapy

3.4

307.7

1954

5644

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

307.7

8279

37082

A46

ICD-10 Finland

Erysipelas

2.8

307.7

6219

23352

C09AA05

ATC

ramipril; oral

1.7

307.7

7213

42653

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.7

307.7

1210

3189

A10BJ01

ATC

exenatide; parenteral

12.0

307.7

786

631

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

25568

183187

XX_20

NOMESCO Finland

Bioimpedance measurement

32.3

307.7

232

E66.8

ICD-10 Finland

Other obesity

155.1

307.7

12821

1181

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.4

307.7

6493

20659

RD210, ,

NOMESCO Finland

7.1

307.7

1273

1737

T83

ICPC

Overweight

5.0

307.7

1370

2633

I10

ICD-10 Finland

Essential (primary) hypertension

2.7

307.7

22877

131067

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.9

307.7

1686

3360

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

17391

100579

WX722

NOMESCO Finland

PEEP

4.9

307.7

2530

5171

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

22701

148799

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

15468

108683

WX290

NOMESCO Finland

Other blockage of nerve

1.6

307.7

18584

132024

C03CA01

ATC

furosemide; systemic

3.3

307.7

11980

44588

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

307.7

2238

8292

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

307.7

4583

15297

S97

ICPC

Chronic ulcer skin

3.2

307.7

2350

7329

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

307.7

14068

93710

M54.5

ICD-10 Finland

Low back pain

1.8

307.7

14313

89070

C09BA02

ATC

enalapril and diuretics; systemic

2.4

307.7

2562

10361

L28

ICPC

Limited function/disability (L)

2.1

307.7

5929

28945

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

14600

100086

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.3

307.7

7162

23419

C10AA05

ATC

atorvastatin; oral

1.6

307.7

12649

85132

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

307.7

4923

20362

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.1

307.7

4398

14456

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

15.9

307.7

465

279

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

10857

53469

A10BJ05

ATC

dulaglutide; parenteral

8.2

307.7

1445

1726

XG466

NOMESCO Finland

Sleep oxymetry

5.9

307.7

1875

3128

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

307.7

2068

7671

162

Kela drug reimbursment

liraglutide

16.8

307.7

1015

584

A10BH01

ATC

sitagliptin; oral

4.1

307.7

4899

12400

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.4

307.7

10201

46875

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

7894

48324

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8590

53386

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

9591

59538

A08AA10

ATC

sibutramine; oral

21.6

307.7

341

150

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.4

307.7

4735

19954

E66.9

ICD-10 Finland

Obesity, unspecified

91.7

307.7

7130

902

A10BB12

ATC

glimepiride; oral

4.0

307.7

2710

6774

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

3107

12505

SPAT1263

SPAT

Sampling

1.7

307.7

15619

106434

C09CA01

ATC

losartan; oral

1.7

307.7

8141

48389

N06AB06

ATC

sertraline; oral

1.9

307.7

4534

23543

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

307.7

7709

42616

160

Kela drug reimbursment

exenatide

16.8

307.7

1922

1132

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

11019

71835

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

22627

170899

P03

ICPC

Feeling depressed

2.0

307.7

4286

21708

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

13.9

307.7

403

276

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

307.7

5219

25461

N06AB04

ATC

citalopram; systemic

2.0

307.7

8285

44235

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

7757

47257

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

307.7

1886

6643

A10BX04

ATC

[U] exenatide

17.9

307.7

917

495

N05AX12

ATC

aripiprazole; systemic

2.9

307.7

1949

6460

N06AB03

ATC

fluoxetine; oral

2.2

307.7

5111

23915

A10BA02

ATC

metformin; oral

4.8

307.7

16361

48830

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

8.9

307.7

4909

5864

B03BA03

ATC

hydroxocobalamin; parenteral

3.9

307.7

2464

6226

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.2

307.7

899

2045

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.9

306.6

1532

5119

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

306.1

1658

5785

K07

ICPC

Swollen ankles/oedema

2.9

306.0

1525

5088

C07AB02

ATC

metoprolol; systemic

1.8

305.9

5763

32829

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.1

304.3

862

2002

I50

ICD-10 Finland

Heart failure

3.9

303.5

941

2334

SPAT1139

SPAT

Nutrition survey

3.1

302.7

1316

4062

S76

ICPC

Skin infection other

2.5

302.4

1993

7670

R53

ICD-10 Finland

Malaise and fatigue

1.6

302.3

8428

53308

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

302.0

5080

27970

K04.0

ICD-10 Finland

Pulpitis

2.0

301.0

3841

19333

SFA20

NOMESCO Finland

Two-surface restoration

1.5

300.2

21686

168657

M01AE02

ATC

naproxen; oral, rectal

1.5

299.9

20632

158850

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

298.7

5618

31966

W84

ICPC

Pregnancy high risk

2.8

298.4

1640

5765

ACC51

NOMESCO Finland

Release of median nerve

2.2

297.8

2852

12908

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.0

297.5

1355

4297

M01AB05

ATC

diclofenac; systemic, rectal

1.5

296.7

23522

186248

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.0

295.2

534

843

207

Kela drug reimbursment

Chronic arrhythmias

1.9

294.7

4132

21461

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

294.6

18935

143566

N05CF01

ATC

zopiclone; oral

1.6

294.5

10344

69040

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

294.3

2646

11673

R06AE07

ATC

cetirizine; oral

1.5

292.9

16104

118258

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

292.1

6397

37963

M79.7

ICD-10 Finland

Fibromyalgia

2.8

292.0

1565

5428

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

289.5

3893

19932

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

287.4

4258

22503

SFA10

NOMESCO Finland

One-surface restoration

1.5

287.1

20155

155190

SFA30

NOMESCO Finland

Three-surface restoration

1.5

286.8

14870

107749

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

286.2

4692

25598

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

285.9

9358

61375

A02BC01

ATC

omeprazole; systemic

1.6

285.8

9077

59115

SPAT1229

SPAT

Assessment of need for aid

2.3

284.7

2421

10434

N05AA02

ATC

levomepromazine; systemic

2.8

284.6

1543

5384

W85

ICPC

Gestational diabetes

2.6

282.4

1770

6645

M01AH05

ATC

etoricoxib; oral

1.5

282.1

22054

173203

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

281.9

8951

58260

T07

ICPC

Weight gain

4.2

279.4

769

1747

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

278.5

25079

202398

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

277.3

4583

25048

Z71.8

ICD-10 Finland

Other specified counselling

1.5

276.4

11257

77401

C09CA06

ATC

candesartan; oral

1.6

275.6

7995

50889

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

275.5

2382

10333

R03AC03

ATC

terbutaline; inhalant

1.8

274.2

4984

28018

R01AD09

ATC

mometasone; nasal

1.5

273.8

16662

124269

J20

ICD-10 Finland

Acute bronchitis

1.9

273.4

3781

19520

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

271.6

1705

6404

S10

ICPC

Boil/carbuncle

2.3

269.5

2184

9216

M10

ICD-10 Finland

Gout

2.8

269.4

1476

5176

C09DA06

ATC

candesartan and diuretics; oral

2.2

269.2

2534

11375

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

268.2

4371

23770

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

265.4

4319

23471

R96

ICPC

Asthma

2.0

265.4

3379

16956

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.0

263.7

778

1861

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

262.1

26657

218950

B01AB04

ATC

dalteparin; parenteral

2.4

261.2

1892

7597

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.5

260.1

1784

6986

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

259.9

9568

64186

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

5.7

259.1

495

824

M48.0

ICD-10 Finland

Spinal stenosis

1.9

257.1

3601

18648

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

256.7

8721

57441

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

256.4

6124

37048

N02AA05

ATC

oxycodone; systemic

1.7

255.9

4984

28533

A10BB01

ATC

glibenclamide; oral

3.4

255.9

983

2812

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

255.4

8762

57830

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

255.2

11631

81563

SPAT1260

SPAT

Consultation of another employee

1.7

255.2

6037

36428

R4110

NOMESCO Finland

Physiotherapy

1.5

254.9

9045

60141

M10.0

ICD-10 Finland

Idiopathic gout

3.1

254.4

1133

3544

R51.80

ICD-10 Finland

Headache

1.7

254.1

5812

34757

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

253.7

11952

84355

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

3.9

252.8

781

1931

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

252.0

2559

11821

B01AF02

ATC

apixaban; oral

1.9

251.8

3436

17635

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

250.9

4246

23324

A01

ICPC

Pain general/multiple sites

2.0

250.5

3113

15476

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

250.5

3934

21122

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

250.4

3784

20072

A06AD11

ATC

lactulose; oral

1.8

250.2

4110

22373

K04.08

ICD-10 Finland

Other specified pulpit

2.0

249.4

3037

14991

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

249.1

11769

83039

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

249.0

1449

5238

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

248.9

4055

22017

SPAT1283

SPAT

Restricted health certificate

1.6

248.8

7171

45419

AA40B, ,

NOMESCO Finland

9.2

247.9

309

318

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

247.1

3578

18717

A10BG02

ATC

rosiglitazone; oral

5.1

247.0

533

992

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

244.5

2554

11921

N06AA09

ATC

amitriptyline; systemic

2.0

244.4

3122

15664

L16

ICPC

Ankle symptom/complaint

1.8

243.9

4051

22116

C01DA14

ATC

isosorbide mononitrate; oral

1.9

243.4

3562

18693

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

243.2

2895

14171

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

242.5

2798

13545

A10BD03

ATC

metformin and rosiglitazone; systemic

4.8

240.5

557

1102

A10AD05

ATC

insulin aspart; parenteral

4.6

238.9

584

1208

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

7.9

238.2

337

407

UJF32

NOMESCO Finland

Coloscopy

1.6

237.9

8140

53554

N02BF01

ATC

gabapentin; oral

2.0

237.6

2851

13992

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.7

236.7

456

765

H02AB07

ATC

prednisone; oral

1.8

236.3

4451

25197

J01MA02

ATC

ciprofloxacin; systemic

1.5

235.7

12420

89293

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

234.8

2827

13888

F34.1

ICD-10 Finland

Dysthymia

2.5

234.8

1505

5704

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

49.3

232.0

141

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

231.8

8139

53808

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.8

231.1

1188

4024

R05

ICPC

Cough

1.5

230.6

8275

54957

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

229.9

2595

12455

SPAT1255

SPAT

Intravenous administration of medicine

2.1

229.5

2266

10345

SPAT1312

SPAT

General health counselling

1.5

229.0

11106

78463

N02BF02

ATC

pregabalin; oral

2.2

229.0

2146

9599

A10BX01

ATC

guar gum; oral

2.9

228.4

1092

3555

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.6

226.7

557

1157

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.2

226.4

929

2767

N05BA01

ATC

diazepam; systemic, rectal

1.8

226.3

4216

23773

D11

ICPC

Diarrhoea

1.7

225.3

4424

25315

J01CA04

ATC

amoxicillin; systemic

1.5

224.1

29926

254543

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

224.0

4189

23642

WZC30

NOMESCO Finland

Teaching

1.7

223.6

5086

30278

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.9

223.5

3183

16536

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

222.8

1724

7119

SPAT1211

SPAT

Application of soft bandage

1.9

222.1

2923

14794

N05AX08

ATC

risperidone; systemic

2.0

221.5

2525

12157

OAB50, ,

SPAT

2.2

221.0

1893

8161

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

220.7

2859

14393

WX402

NOMESCO Finland

General anaesthesia

1.6

220.7

7339

47865

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

220.5

2988

15270

107

Kela drug reimbursment

Pernicious anaemia

3.9

219.1

659

1598

S80.0

ICD-10 Finland

Contusion of knee

2.0

219.0

2745

13662

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

218.1

3290

17402

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.1

217.8

476

896

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

217.6

1141

3905

A10BH02

ATC

vildagliptin; oral

3.9

217.6

673

1665

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.5

217.3

785

2158

R03BA01

ATC

beclometasone; inhalant

1.7

216.8

4638

27150

C09CA03

ATC

valsartan; oral

1.9

216.7

2793

14033

M02AA07

ATC

piroxicam; topical

1.5

216.0

11035

78547

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

215.2

3203

16868

J01FA09

ATC

clarithromycin; systemic

1.5

213.4

10836

77001

N62

ICD-10 Finland

Hypertrophy of breast

2.4

211.8

1618

6641

J01CF05

ATC

flucloxacillin; systemic

2.1

211.8

2179

10097

L90

ICPC

Osteoarthrosis of knee

2.1

211.5

2048

9271

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

13.0

210.4

208

151

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

209.4

3394

18343

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.7

209.3

4483

26231

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

209.0

4532

26606

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

208.4

4535

26646

E61.2

ICD-10 Finland

Magnesium deficiency

63.5

208.3

121

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

206.9

9355

64925

D07AC01

ATC

betamethasone; topical

1.4

206.5

11913

86567

H02AB04

ATC

methylprednisolone; systemic

1.7

206.5

4709

28006

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.1

205.4

2086

9616

A02BC05

ATC

esomeprazole; systemic

1.4

205.3

13416

99660

R5110, ,

SPAT

2.1

205.1

2000

9077

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

204.4

1843

8109

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

204.0

13194

97802

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

204.0

1261

4692

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

203.5

5651

35282

N06AX26

ATC

vortioxetine; oral

1.9

203.0

2769

14166

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

202.6

2381

11577

C08CA02

ATC

felodipine; oral

2.0

202.3

2546

12677

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.8

199.2

623

1553

B01AB10

ATC

tinzaparin; parenteral

1.8

199.2

3254

17617

E0000UV, ,

ATC

1.4

198.7

14271

107583

R03DA04

ATC

theophylline; systemic, rectal

2.4

198.5

1426

5693

Z3229

NOMESCO Finland

Other healthcare associate professional

1.9

198.1

2610

13195

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

198.1

8106

55064

WX002

NOMESCO Finland

Sedation and analgesia

1.6

197.5

5891

37374

R74

ICPC

Upper respiratory infection acute

1.4

197.1

11951

87443

M54

ICD-10 Finland

Dorsalgia

1.7

196.9

4426

26200

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

195.7

3000

15923

A10BX09

ATC

[U] dapagliflozin

5.3

195.3

404

724

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

194.2

8047

54768

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

193.5

843

2601

A12BA01

ATC

potassium chloride; oral

2.7

193.2

1051

3666

H3600, E113,

ICD-10 Finland

4.8

193.2

443

869

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

193.1

2275

11065

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.4

192.8

1411

5680

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

192.7

12961

96469

A02BC03

ATC

lansoprazole; oral

1.5

192.0

8850

61486

WX320

NOMESCO Finland

Spinalanesthesy

1.5

192.0

7567

50961

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

191.6

4150

24316

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

191.3

9943

70662

L60.0

ICD-10 Finland

Ingrowing nail

2.2

191.2

1662

7201

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

190.6

5197

32256

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.5

189.6

1242

4750

RD112, ,

NOMESCO Finland

11.9

189.1

198

158

SPAT1216

SPAT

Assessment of functional ability

1.7

188.6

4241

25086

N05CD07

ATC

temazepam; oral

1.8

187.8

3167

17294

C07AG02

ATC

carvedilol; oral

2.2

187.7

1623

7016

N18.8

ICD-10 Finland

Other chronic renal failure

3.2

187.4

779

2337

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

186.8

3868

22384

26998

ICD-8 Finland

Other nutritional deficiency, Aliae definitae

+∞

186.4

183

RD140, ,

NOMESCO Finland

88.4

185.5

103

R06.2

ICD-10 Finland

Wheezing

2.2

185.1

1584

6817

K08.3

ICD-10 Finland

Retained dental root

1.9

184.5

2407

12120

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

4.8

184.0

424

835

P29

ICPC

Psychological sympt/compl other

1.9

183.4

2675

13968

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

183.2

4789

29400

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

182.6

2345

11744

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

182.3

4042

23807

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

182.1

977

3383

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

181.2

2138

10398

F32

ICD-10 Finland

Depressive episode

2.0

181.2

2130

10346

A03

ICPC

Fever

1.5

180.9

6131

39935

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

180.0

1149

4340

S29

ICPC

Skin symptom/complaint other

1.5

179.7

6037

39240

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

179.7

1126

4215

N06AX03

ATC

mianserin; oral

2.2

179.7

1565

6783

P99

ICPC

Psychological disorders other

2.5

179.4

1178

4510

F50.8

ICD-10 Finland

Other eating disorders

6.6

179.1

296

426

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

178.9

757

2295

SGC10

NOMESCO Finland

Pulp capping

1.7

178.3

3284

18385

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

178.1

7938

54663

Z2446

NOMESCO Finland

Social worker

2.0

177.9

2189

10802

R11

ICD-10 Finland

Nausea and vomiting

1.8

177.4

2861

15404

ZY010

NOMESCO Finland

Hospital outpatient

2.1

177.0

1908

8981

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

176.3

3156

17522

XA420

NOMESCO Finland

Extensive sleep examination

4.2

175.9

477

1071

A04

ICPC

Weakness/tiredness general

1.6

175.3

4776

29587

C09DA03

ATC

valsartan and diuretics; oral

2.3

175.2

1451

6158

B01AF01

ATC

rivaroxaban; oral

1.7

174.5

3454

19723

AA1AD

NOMESCO Finland

CT of head and brain

1.5

173.7

7665

52640

M01AH01

ATC

celecoxib; oral

1.6

173.7

5469

35018

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

2.9

171.7

847

2803

L73.2

ICD-10 Finland

Hidradenitis suppurativa

3.9

171.1

518

1262

N05AN01

ATC

lithium; oral

2.7

170.9

953

3366

D01AC02

ATC

miconazole; topical

1.9

170.6

2271

11503

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

169.6

998

3622

N05AF03

ATC

chlorprothixene; systemic

2.6

168.5

985

3563

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

167.5

3401

19543

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

167.5

792

2560

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

167.2

2772

15040

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

167.1

8438

59375

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

166.8

1290

5316

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

165.3

24190

201761

H3601, E113,

ICD-10 Finland

4.0

165.2

480

1135

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

164.6

2725

14774

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

164.1

3685

21741

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.6

164.0

3975

23907

C10AA07

ATC

rosuvastatin; oral

1.4

164.0

9355

67236

J02AC01

ATC

fluconazole; systemic

1.4

164.0

13966

107214

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.7

163.3

928

3309

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

163.2

6523

43861

I50.1

ICD-10 Finland

Left ventricular failure

2.4

163.0

1195

4810

J01FA10

ATC

azithromycin; systemic

1.3

162.6

20550

167384

J01DA09

ATC

[U] cefadroxil

1.4

162.2

8790

62587

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

161.5

3166

18011

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

161.2

4682

29395

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

161.1

8948

63972

N05AH03

ATC

olanzapine; systemic

1.9

161.0

2141

10836

N19

ICD-10 Finland

Unspecified kidney failure

2.6

160.7

942

3411

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.7

160.3

3446

20092

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

160.1

668

2008

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

159.7

631

1835

R42

ICD-10 Finland

Dizziness and giddiness

1.5

159.1

6785

46182

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.8

158.9

812

2739

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

158.7

1508

6762

N03AG01

ATC

valproic acid; systemic, rectal

1.9

158.7

2007

9986

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.1

158.5

1557

7072

J45.8

ICD-10 Finland

Mixed asthma

2.5

158.2

1053

4055

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

157.8

7232

49898

A10AE06

ATC

insulin degludec; parenteral

2.3

157.7

1201

4915

E51.2

ICD-10 Finland

Wernicke encephalopathy

380.8

157.7

162

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

157.3

2153

10998

G44.2

ICD-10 Finland

Tension-type headache

1.6

156.9

4740

30009

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

156.8

2256

11710

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

156.7

2608

14155

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.6

156.1

3746

22458

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

155.8

6136

41091

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

155.5

9235

66720

C01AA05

ATC

digoxin; systemic

2.1

155.2

1630

7593

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

154.8

2669

14636

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

154.2

5776

38282

R50.9

ICD-10 Finland

Fever, unspecified

1.6

154.0

4716

29938

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

153.0

3324

19424

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

152.4

9515

69282

B02AA02

ATC

tranexamic acid; systemic

1.5

152.0

5057

32683

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

151.7

6849

47072

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

151.1

1786

8679

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

151.1

3715

22396

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

151.0

786

2677

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.1

151.0

430

1002

WX725

NOMESCO Finland

Noninvasive ventilation

2.0

150.7

1787

8694

R01AD08

ATC

fluticasone; nasal

1.4

150.7

9682

70810

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

150.7

4803

30751

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

150.6

12041

91197

R03AC13

ATC

formoterol; inhalant

2.1

150.5

1548

7154

SPAT1234

SPAT

Support of social functional capacity

2.2

150.1

1412

6306

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

149.8

1707

8189

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

148.8

3162

18363

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

148.2

854

3066

H01

ICPC

Ear pain/earache

1.6

148.1

4010

24732

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

148.1

14281

111175

L30.4

ICD-10 Finland

Erythema intertrigo

3.5

147.8

535

1472

ZXE00

NOMESCO Finland

One hour or less

1.3

147.6

12616

96453

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.9

146.2

700

2278

E000001, ,

ATC

1.5

145.8

6515

44646

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

145.4

645

2010

AN1

Coronary angiography

1.7

144.7

2631

14638

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

144.7

3009

17370

P01

ICPC

Feeling anxious/nervous/tense

1.5

144.6

4535

28909

SPAT1097

SPAT

Recording of ECG

1.6

144.5

4057

25226

M79.1

ICD-10 Finland

Myalgia

1.5

144.5

4840

31299

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

144.4

11791

89439

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

143.8

752

2567

L14

ICPC

Leg/thigh symptom/complaint

1.8

143.6

2422

13185

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

143.6

1010

3989

D07AC13

ATC

mometasone; topical

1.4

143.5

9217

67301

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.9

143.5

1960

9998

XG410

NOMESCO Finland

Flow-volume spirometry

2.2

143.2

1222

5246

SPAT1281

SPAT

Other administrative function

1.8

142.9

2526

13940

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

142.9

1295

5697

R04

ICPC

Breathing problem other

2.2

142.7

1239

5357

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

142.7

2788

15824

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.7

142.2

457

1161

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

142.1

4915

31990

SPAT1104

SPAT

Monitoring of emergency patient

1.9

141.9

1955

9998

N06AX05

ATC

trazodone; oral

2.5

141.8

936

3590

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

141.5

1892

9583

ZXA00

NOMESCO Finland

Right side

1.4

140.8

7444

52557

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

140.8

592

1788

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

140.0

2007

10395

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.2

140.0

1302

5786

R03AC12

ATC

salmeterol; inhalant

2.2

139.9

1289

5707

A10BD20

ATC

metformin and empagliflozin; oral

3.5

139.9

499

1360

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

139.9

1715

8436

SPAT1153

SPAT

Removal of sutures

1.4

139.7

9352

68687

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

139.5

2334

12673

M01AX17

ATC

nimesulide; oral

1.4

139.3

6768

47054

J01MA14

ATC

moxifloxacin; systemic

1.7

139.1

2669

15067

SPAT1377

SPAT

Polysomnography

2.3

138.6

1125

4729

J96.0

ICD-10 Finland

Acute respiratory failure

4.0

138.6

405

962

L86

ICPC

Back syndrome with radiating pain

1.9

138.5

1918

9825

E68

ICD-10 Finland

Sequelae of hyperalimentation

41.0

137.3

A10AB06

ATC

insulin glulisine; parenteral

4.0

136.9

401

954

N05AB03

ATC

perphenazine; systemic, rectal

2.2

136.9

1147

4887

R01AD12

ATC

fluticasone furoate; nasal

1.3

136.5

11080

83797

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

136.4

3288

19697

M01AC06

ATC

meloxicam; systemic, rectal

1.3

135.7

11179

84719

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.3

134.9

533

1550

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

134.8

1216

5339

M01AX05

ATC

glucosamine; oral

1.5

134.6

4868

31949

CL2S4, ,

SPAT

3.3

134.0

524

1514

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

133.5

871

3322

R52.9

ICD-10 Finland

Pain, unspecified

1.6

133.3

3122

18563

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

133.3

919

3596

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

2.9

132.3

661

2202

SPAT1094

SPAT

Continuous Positive Airway Pressure

3.7

132.2

427

1089

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.3

131.9

1017

4182

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

131.9

5463

36820

SPAT1058

SPAT

PEF monitoring instruction

1.7

131.8

2453

13725

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

131.6

1697

8488

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

131.3

819

3057

EBA30

NOMESCO Finland

Extraction of root of tooth

1.9

131.2

1657

8231

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

131.1

2974

17538

N03AX11

ATC

topiramate; oral

2.4

131.1

955

3831

R4110, ,

SPAT

1.7

130.8

2578

14653

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

130.7

1359

6301

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.4

130.6

907

3560

C03BA11

ATC

indapamide; oral

2.6

130.6

793

2921

L08

ICPC

Shoulder symptom/complaint

1.4

130.5

6625

46357

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

130.3

2576

14653

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

130.0

3623

22454

C10AB05

ATC

fenofibrate; oral

3.0

128.7

600

1924

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

128.6

1790

9180

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.7

128.4

740

2656

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

128.3

2509

14226

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

128.2

6500

45450

A02BA02

ATC

ranitidine; systemic

1.5

127.4

5251

35335

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

127.4

1357

6348

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

127.3

3811

23999

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

127.0

1807

9331

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

126.8

3784

23809

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

126.4

1715

8721

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.0

126.3

562

1755

R01AD58

ATC

fluticasone, combinations; nasal

1.4

126.2

8571

62907

M01AB01

ATC

indometacin; systemic, rectal

1.8

126.1

1875

9816

XF402

NOMESCO Finland

ECG with work load test

1.7

125.9

2827

16621

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

125.5

955

3905

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

125.1

1066

4572

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.1

124.7

1190

5340

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

124.4

1232

5607

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

124.4

752

2764

U04

ICPC

Incontinence urine

2.0

124.2

1393

6637

N05BA12

ATC

alprazolam; oral

1.6

124.2

3033

18207

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.8

123.9

623

2083

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

123.6

4107

26444

SPAT1054

SPAT

Examination of peripheral nervous system

3.1

123.4

545

1694

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.6

123.1

724

2625

F50.3

ICD-10 Finland

Atypical bulimia nervosa

4.9

123.1

277

535

K04.09

ICD-10 Finland

Pulpit UNS

1.9

123.1

1594

7981

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

123.0

1169

5237

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

122.7

1935

10312

XQ800

NOMESCO Finland

Prick test

1.7

122.6

2556

14738

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.1

122.6

1210

5500

N06AB05

ATC

paroxetine; oral

1.8

122.3

1983

10657

C10AX09

ATC

ezetimibe; oral

1.5

122.2

4218

27370

K77

ICPC

Heart failure

3.1

122.2

526

1611

Z01.2

ICD-10 Finland

Dental examination

1.3

121.7

15722

126302

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

121.6

1023

4364

D07AD01

ATC

clobetasol; topical

1.5

121.6

5083

34267

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.9

121.6

597

1970

D10

ICPC

Vomiting

1.7

121.6

2173

12012

ZXA05

NOMESCO Finland

Left side

1.4

121.6

6831

48565

JAH01

NOMESCO Finland

Laparoscopy

1.9

121.2

1540

7662

L68.0

ICD-10 Finland

Hirsutism

4.3

121.1

318

697

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

120.9

783

2975

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

120.9

1365

6519

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

120.9

1681

8614

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

120.4

2977

17920

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.2

120.3

1071

4676

D07XC01

ATC

betamethasone; topical

1.6

120.0

3514

22004

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

119.8

1874

9961

N05CF02

ATC

zolpidem; oral

1.4

119.8

5510

37808

Z2221

NOMESCO Finland

Medical doctor

1.4

119.6

8710

64533

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

119.1

563

1819

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

118.4

1654

8487

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

118.3

1118

4997

E87.6

ICD-10 Finland

Hypokalaemia

2.3

117.8

979

4155

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

117.6

3732

23778

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

117.6

1001

4291

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

117.4

1774

9329

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

117.3

1487

7390

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

117.2

2032

11134

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.4

116.6

860

3468

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

116.1

114

K78

ICPC

Atrial fibrillation/flutter

1.8

115.8

1723

9017

N30.0

ICD-10 Finland

Acute cystitis

1.4

115.7

5072

34471

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

115.6

4087

26633

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

115.0

1162

5327

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

114.6

1194

5537

RK320, ,

NOMESCO Finland

4.3

114.1

302

666

A08AX01

ATC

rimonabant; oral

20.0

114.0

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.5

113.3

758

2924

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

113.3

1804

9638

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

112.9

1414

6999

A10BX02

ATC

repaglinide; oral

3.6

112.6

386

1025

C09CA07

ATC

telmisartan; oral

1.7

112.6

2057

11434

N01

ICPC

Headache

1.5

112.6

3792

24455

KGH10

NOMESCO Finland

Operation for phimosis

2.5

112.4

720

2722

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

112.3

1874

10150

SPAT1051

SPAT

Guidance regarding sleep disorders

2.8

112.0

581

1975

G04BD12

ATC

mirabegron; oral

1.6

112.0

3003

18413

T92

ICPC

Gout

2.9

111.8

558

1858

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.9

111.8

342

840

M02AA10

ATC

ketoprofen; topical

1.5

111.5

4583

30755

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

111.3

2233

12735

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

111.2

937

3999

L13

ICPC

Hip symptom/complaint

1.4

111.1

5043

34472

D07AA02

ATC

hydrocortisone; topical

1.5

111.1

4475

29911

R21

ICPC

Throat symptom/complaint

1.4

110.9

7490

54745

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

110.6

1468

7406

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.0

110.5

325

776

G93.2

ICD-10 Finland

Benign intracranial hypertension

7.7

110.3

158

194

R52.2

ICD-10 Finland

Other chronic pain

2.1

110.2

1151

5342

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

109.9

1971

10897

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.6

109.9

652

2374

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.7

109.8

2104

11850

A99

ICPC

Disease/condition unspecnature/site

1.6

109.8

2699

16208

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

109.6

675

2504

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.3

109.6

856

3539

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

109.5

1709

9073

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

109.3

9376

70979

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

109.1

913

3885

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

18.5

108.9

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

108.4

1142

5318

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.5

108.3

711

2719

CK2S4, ,

SPAT

3.1

108.2

463

1413

ZXA10

NOMESCO Finland

Bilateral

1.4

108.1

5143

35441

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.1

107.8

1114

5150

M01AH02

ATC

rofecoxib; oral

1.5

107.7

3370

21381

C07BB07

ATC

bisoprolol and thiazides; systemic

2.1

107.7

1037

4667

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

107.6

1628

8560

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.7

107.4

604

2141

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

107.2

1286

6271

A10AB04

ATC

insulin lispro; parenteral

2.1

106.8

1017

4557

A08AA01

ATC

phentermine; oral

6.2

106.8

186

283

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

106.6

553

1880

N06AA12

ATC

doxepin; systemic

1.9

106.5

1402

7054

UJD02

NOMESCO Finland

Gastroscopy

1.9

106.3

1311

6453

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.8

105.9

1837

10060

KMAK, ,

NOMESCO Finland

1.3

105.7

17664

145573

N04BC05

ATC

pramipexole; oral

1.7

105.6

2057

11635

J96.9

ICD-10 Finland

Respiratory failure, unspecified

4.9

105.2

238

462

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

105.2

1186

5659

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

104.7

1531

7965

K85

ICPC

Elevated blood pressure

1.5

104.6

4100

27236

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

104.6

3012

18760

C08DB01

ATC

diltiazem; oral

2.1

104.5

1101

5126

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.8

104.3

536

1813

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

104.0

2149

12345

R29

ICPC

Respiratory symptom/complaint other

1.7

104.0

2083

11869

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

103.9

2165

12466

R06AX27

ATC

desloratadine; oral

1.3

103.7

9764

74774

B80

ICPC

Iron deficiency anaemia

2.3

103.3

789

3230

EB1VA, ,

NOMESCO Finland

1.5

103.2

3986

26399

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

103.1

1165

5563

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

103.0

3164

19984

A11CC03

ATC

alfacalcidol; systemic

2.5

102.9

690

2665

WX892

NOMESCO Finland

Monitored bed care

1.7

102.9

2078

11866

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

102.8

2130

12243

C09DA07

ATC

telmisartan and diuretics; oral

2.0

102.8

1174

5626

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

102.7

898

3890

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

102.5

2998

18732

N05AE04

ATC

ziprasidone; systemic

4.0

102.2

298

707

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

101.6

721

2857

SPAT1059

SPAT

Spirometry at the office

1.9

101.6

1433

7370

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

101.6

1560

8238

Z01.7

ICD-10 Finland

Laboratory examination

1.4

101.5

4448

30164

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.7

101.0

547

1902

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

100.9

1830

10144

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

5.7

100.8

191

316

A08AA04

ATC

dexfenfluramine; oral

8.9

100.3

128

136

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

100.3

951

4255

C09AA03

ATC

lisinopril; oral

2.0

100.3

1132

5403

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.8

100.3

1482

7735

E000003, ,

ATC

1.9

100.0

1363

6933

ZX120

NOMESCO Finland

Intravenous

1.6

100.0

2678

16398

M09AX01

ATC

hyaluronic acid; parenteral

2.0

99.9

1141

5469

R52.0

ICD-10 Finland

Acute pain

2.0

99.8

1083

5096

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.8

99.8

524

1793

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.3

99.7

754

3074

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

99.5

3712

24405

J01DA06

ATC

[U] cefuroxime

1.4

99.4

4325

29282

R99

ICPC

Respiratory disease other

2.6

99.3

595

2178

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

99.2

1895

10656

S21

ICPC

Skin texture symptom/complaint

1.5

99.2

4120

27654

RD160, ,

NOMESCO Finland

8.2

99.1

135

156

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

99.1

775

3206

P74

ICPC

Anxiety disorder/anxiety state

1.8

99.0

1497

7869

A29

ICPC

General symptom/complaint other

1.5

98.9

3491

22694

Z2445

NOMESCO Finland

Psychologist

1.9

98.7

1319

6666

QBJ00

NOMESCO Finland

Liposuction in trunk

4.4

98.7

250

533

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.6

98.6

340

907

SPAT1252

SPAT

Overall medication plan or its review

1.8

98.6

1718

9417

E87.5

ICD-10 Finland

Hyperkalaemia

2.9

98.4

464

1498

M15

ICD-10 Finland

Polyarthrosis

1.9

98.0

1305

6588

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

97.7

965

4385

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

97.3

714

2872

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

97.2

1231

6112

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.4

97.1

248

532

O61.0

ICD-10 Finland

Failed medical induction of labour

3.2

97.1

404

1213

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

97.0

719

2905

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

96.9

807

3427

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

96.5

3003

19009

L12

ICPC

Hand/finger symptom/complaint

1.4

96.3

4961

34598

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

96.0

548

1958

Z50.1

ICD-10 Finland

Other physical therapy

1.8

95.9

1493

7915

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

95.7

1414

7378

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

95.7

673

2657

S20

ICPC

Corn/callosity

2.6

95.6

575

2108

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

95.3

1154

5643

-1, ,

NOMESCO Finland

1.3

95.3

11022

86499

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

94.8

1541

8276

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.0

94.5

1007

4707

Z72.0

ICD-10 Finland

Tobacco use

2.2

94.4

848

3714

X58

ICD-10 Finland

Exposure to other specified factors

1.4

94.3

4364

29858

K92.1

ICD-10 Finland

Melaena

1.9

94.3

1319

6764

C02EA02, ,

ATC

2.2

94.3

871

3857

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.2

94.3

391

1172

N06AG02

ATC

moclobemide; oral

1.9

94.2

1255

6336

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.5

94.1

621

2381

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

93.8

717

2937

N05BE01

ATC

buspirone; oral

2.1

93.4

918

4163

R06AX22

ATC

ebastine; oral

1.4

93.3

5484

39076

D01

ICPC

Abdominal pain/cramps general

1.5

93.1

3752

25019

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

93.1

976

4535

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.5

92.8

3195

20649

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.4

92.8

235

501

SPAT1379

SPAT

Health check-up of pregnant person

1.5

92.7

3654

24263

TK800

NOMESCO Finland

Hemodialysis

2.5

92.7

626

2426

R03BA08

ATC

ciclesonide; inhalant

1.6

92.3

2664

16581

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

92.1

768

3263

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.5

92.1

1155

19680

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

91.9

3628

24093

R4180, ,

SPAT

3.6

91.6

315

839

K80.8

ICD-10 Finland

Other cholelithiasis

2.6

91.6

549

2010

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

91.5

503

1763

WVA30, ,

SPAT

1.8

91.5

1512

8159

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

91.4

1837

10468

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.1

91.3

915

4181

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.6

91.1

2260

13580

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

91.1

1414

7489

A05

ICPC

Feeling ill

1.7

91.0

1980

11517

B01AC04

ATC

clopidogrel; oral

1.5

90.7

3675

24522

N07BB01

ATC

disulfiram; oral

1.8

90.7

1310

6785

212

Kela drug reimbursment

Gout

2.8

90.4

475

1626

D07AB08

ATC

desonide; topical

1.5

90.3

3240

21114

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

89.9

791

3436

N06AX22

ATC

agomelatine; oral

2.2

89.8

820

3614

SPAT1251

SPAT

Organisation of medication

2.1

89.7

926

4277

A10BD15

ATC

metformin and dapagliflozin; oral

3.6

89.7

304

802

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.0

89.5

942

4383

SGB30

NOMESCO Finland

Other complicated root filling

1.4

89.4

3850

25982

D06AX01

ATC

fusidic acid; topical

1.5

89.4

2824

17922

M76.6

ICD-10 Finland

Achilles tendinitis

1.8

89.3

1486

8033

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

89.3

7501

56341

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

89.2

4748

33261

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

88.8

1281

6632

RD130, ,

NOMESCO Finland

23.9

88.7

J01FA01

ATC

erythromycin; systemic

1.4

88.7

4499

31257

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

88.6

801

3516

L02

ICPC

Back symptom/complaint

1.5

88.6

3135

20368

S01

ICPC

Pain/tenderness of skin

1.8

88.5

1332

6987

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

88.4

716

3006

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

88.1

2013

11853

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

88.1

2140

12792

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

4.0

88.1

252

590

E03

ICD-10 Finland

Other hypothyroidism

1.7

88.0

1790

10231

104

Kela drug reimbursment

Thyroid insufficiency

1.6

87.9

1938

11309

I11

ICD-10 Finland

Hypertensive heart disease

5.0

87.9

192

362

N03AE01

ATC

clonazepam; systemic

1.7

87.9

1609

8938

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

87.6

1348

7119

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.0

87.5

968

4586

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

87.5

3008

19426

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

87.4

940

4408

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.4

87.3

595

2315

-50

ICPC

Medication/prescr/renewal

1.9

87.3

1111

5524

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.8

87.3

1418

7612

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

87.2

2764

17548

UKC02

NOMESCO Finland

Cystoscopy

1.4

87.2

3843

26037

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

87.1

32550

292282

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.8

87.1

449

1522

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

87.0

591

2297

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

1.5

86.7

2683

16946

E50.9

ICD-10 Finland

Vitamin A deficiency, unspecified

+∞

86.5

SPAT1151

SPAT

Treatment of major wounds

3.1

86.5

363

1096

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

86.5

534

1984

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

86.4

1334

7053

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

86.4

1007

4860

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

86.2

1014

4909

WZC00, ,

SPAT

1.5

86.2

3067

19943

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.5

86.1

559

2127

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.7

85.9

1715

9752

L29

ICPC

Musculoskeletal sympt/complt other

1.6

85.7

2456

15254

AA43B, ,

NOMESCO Finland

22.7

85.7

QDB10, ,

SPAT

2.6

85.4

491

1761

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.9

85.2

405

1314

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

85.1

413

1355

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.5

85.0

2789

17832

JDF21

NOMESCO Finland

Laparoscopic gastric banding

800.8

84.6

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

84.5

1932

11374

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

84.1

1717

9819

OAB42, ,

SPAT

1.5

84.1

3123

20476

C07AA05

ATC

propranolol; systemic

1.3

84.0

6489

48105

I20.09

ICD-10 Finland

Unstable angina

1.8

83.9

1261

6611

D50

ICD-10 Finland

Iron deficiency anaemia

2.2

83.9

748

3266

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

83.8

621

2509

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

83.8

857

3945

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

83.8

1816

10549

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

83.8

1809

10498

C08CA10

ATC

nilvadipine; oral

2.6

83.4

501

1836

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

83.1

3052

19965

SPAT1360

SPAT

Extensive global examination

1.6

82.8

1915

11307

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

82.6

1654

9410

D05AX52

ATC

calcipotriol, combinations; topical

1.7

82.6

1574

8838

J01FA15

ATC

telithromycin; oral

1.5

82.4

2926

19011

R05

ICD-10 Finland

Cough

1.3

82.2

6330

46887

L01

ICPC

Neck symptom/complaint

1.4

82.2

4792

34032

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

82.2

1009

4956

C10AB02

ATC

bezafibrate; oral

3.3

82.1

312

887

F32.8

ICD-10 Finland

Other depressive episodes

2.4

82.0

563

2199

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.1

81.9

358

1107

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.1

81.8

854

3961

NG2AA

NOMESCO Finland

Patella X-ray examination

2.1

81.7

774

3461

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.0

81.6

379

1214

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.3

81.5

665

2801

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

81.4

2878

18678

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

81.4

2102

12743

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.9

81.4

401

1327

A10BD08

ATC

metformin and vildagliptin; systemic

3.7

81.3

261

664

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

81.2

3107

20482

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

3.8

81.2

256

643

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.8

81.2

1211

6335

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

81.0

1725

9973

G04BD08

ATC

solifenacin; oral

1.7

81.0

1592

9013

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

80.5

759

3388

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.3

80.4

652

2738

WX111

NOMESCO Finland

Local infiltration anesthesia

2.0

80.3

896

4257

R04.0

ICD-10 Finland

Epistaxis

1.6

80.3

1815

10654

H36.01

ICD-10 Finland

Diabetic maculopathy

2.8

80.2

409

1379

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

79.9

1229

6489

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.4

79.8

546

2129

M54.3

ICD-10 Finland

Sciatica

1.7

79.6

1699

9827

WZA00

NOMESCO Finland

Concise certificate

1.6

79.5

1991

11982

N05AH02

ATC

clozapine; systemic

2.4

79.4

588

2375

R07.3

ICD-10 Finland

Other chest pain

1.5

79.3

2796

18135

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

6.9

79.1

124

169

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

79.0

2245

13907

A12AA04

ATC

calcium carbonate; oral

2.7

78.9

443

1570

D09AB01

ATC

zinc bandage without supplements; topical

2.4

78.9

564

2243

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

78.9

2926

19169

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

78.7

1009

5028

E86

ICD-10 Finland

Volume depletion

2.4

78.7

577

2321

Z08

ICPC

Social welfare problem

2.7

78.6

438

1547

C09BA03

ATC

lisinopril and diuretics; oral

2.4

78.3

571

2291

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

78.0

1462

8169

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.7

78.0

444

1585

K86

ICPC

Hypertension uncomplicated

1.5

77.9

3022

19966

K03.66

ICD-10 Finland

Tooth plaque

1.6

77.7

2120

13011

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

77.7

1116

5769

D02AE01

ATC

carbamide; topical

1.6

77.7

1872

11161

EMB10

NOMESCO Finland

Tonsillectomy

1.6

77.6

1936

11637

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.4

77.3

540

2126

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.5

77.3

493

1861

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

77.2

420

1465

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

77.2

1477

8300

WX704

NOMESCO Finland

Intubation

1.5

77.2

2360

14855

WVA20, ,

SPAT

2.1

77.1

747

3369

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

77.1

2214

13747

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

77.0

12903

105034

C10AC01

ATC

colestyramine; oral

2.0

76.9

808

3757

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

76.8

1290

6989

R60.1

ICD-10 Finland

Generalized oedema

3.6

76.6

262

696

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.4

76.5

278

768

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

76.4

844

3996

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

76.4

1143

5984

D01AE15

ATC

terbinafine; topical

1.6

76.3

1837

10947

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

76.1

1278

6925

S22

ICPC

Nail symptom/complaint

1.6

75.9

1757

10371

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

75.8

1269

6868

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.0

75.8

817

3834

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

75.7

764

13948

C08CA05

ATC

nifedipine; systemic

1.7

75.6

1486

8411

XA421

NOMESCO Finland

Nocturnal polygraphy

4.0

75.5

216

506

H3603, E113,

ICD-10 Finland

3.6

75.4

257

681

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

75.3

1038

5296

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

75.1

545

2182

NHQ40

NOMESCO Finland

Amputation of toe

2.7

75.0

408

1423

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

75.0

482

1826

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

75.0

625

2656

J01

ICD-10 Finland

Acute sinusitis

1.6

74.8

1762

10443

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.1

74.8

324

997

R06AX13

ATC

loratadine; oral

1.4

74.8

4746

34117

N07BA03

ATC

varenicline; oral

1.7

74.6

1491

8477

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

74.5

1390

7756

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.4

74.3

4735

34055

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

74.0

1097

5725

C09DB01

ATC

valsartan and amlodipine; oral

2.0

74.0

878

4262

L11

ICPC

Wrist symptom/complaint

1.5

74.0

2690

17545

J01CA08

ATC

pivmecillinam; oral

1.2

73.9

13070

106867

R09

ICPC

Sinus symptom/complaint

1.5

73.8

2622

17020

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

73.7

887

4327

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

73.6

763

3531

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.1

73.5

762

3526

WX110, ,

SPAT

1.6

73.4

1829

10988

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

2.1

73.3

710

3203

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

73.1

530

2122

SPAT1202

SPAT

Intra-articular injection

2.0

73.0

782

3662

J01DC02

ATC

cefuroxime; systemic

1.6

72.9

1651

9692

D01AC03

ATC

econazole; topical

1.7

72.7

1532

8830

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

72.6

829

3972

A97

ICPC

No disease

1.3

72.4

5180

37893

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

72.2

384

1324

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

72.1

4239

30095

L03.3

ICD-10 Finland

Cellulitis of trunk

3.3

72.1

278

798

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

71.9

963

4868

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

71.8

965

4883

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

71.8

653

2874

WZC30, ,

SPAT

1.7

71.6

1504

8662

SPAT1172

SPAT

Guidance concerning hydration

2.4

71.4

507

2011

F31

ICD-10 Finland

Bipolar affective disorder

2.5

71.3

445

1662

N06AA10

ATC

nortriptyline; systemic

2.2

71.3

646

2839

SPAT1325

SPAT

Vaccination

1.3

71.2

9229

72861

C10AA04

ATC

fluvastatin; oral

1.6

71.1

1831

11085

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.2

71.1

623

2702

A10BB07

ATC

glipizide; oral

3.4

70.9

259

718

IGY02, ,

SPAT

2.6

70.9

417

1513

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.7

70.8

1364

7676

SPAT1285

SPAT

Provision of consultation response

1.7

70.8

1437

8202

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.2

70.7

288

855

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

70.5

1348

7573

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.8

70.3

1162

6266

RD250, ,

NOMESCO Finland

+∞

70.2

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.1

70.2

681

3073

M54.1

ICD-10 Finland

Radiculopathy

1.8

70.2

1142

6130

N17

ICPC

Vertigo/dizziness

1.4

70.1

3190

21689

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

70.0

825

3995

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.1

70.0

701

3202

O99.80

ICD-10 Finland

The fear of childbirth

1.6

70.0

1551

9054

D09

ICPC

Nausea

1.7

69.9

1433

8198

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

69.9

875

4326

G04BD07

ATC

tolterodine; oral

1.8

69.8

1094

5808

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.0

69.8

784

3735

F33.8

ICD-10 Finland

Other recurrent depressive disorders

2.9

69.6

335

1095

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

1.8

69.5

988

5089

R4120

NOMESCO Finland

Occupational therapy

1.6

69.5

1809

10976

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

69.4

539

2223

L84

ICD-10 Finland

Corns and callosities

1.9

69.3

939

4765

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015736) pH of Urine

15849

114954

1.52

312.90

3.9

3.1

5.74

5.90

7.57

1071

10296

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4314

22417

1.92

308.08

9.9

8.2

124.42

121.60

g/l

14.28

4230

21789

(3022217) INR in Platelet poor plasma by Coagulation assay

18801

116386

2.05

307.65

16.0

12.0

1.22

1.20

inr

1.54

5456

35172

(3013512) EKG study

11517

72745

1.71

307.65

4.6

3.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

18599

116491

2.00

307.65

7.5

5.8

1.21

mmol/l

25.77

17254

106649

(3012516) Albumin [Mass/volume] in Urine

15233

69999

2.77

307.65

3.7

3.2

253.59

443.97

mg/l

8.15

10629

43888

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7066

39680

1.83

307.65

2.0

1.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1693

5704

2.88

307.65

3.6

2.9

25.15

24.49

mmol/l

7.00

1660

5568

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

33412

284206

2.01

307.65

5.3

4.0

1.28

1.49

mmol/l

307.65

31426

265950

(3026008) Bacteria identified in Urine by Culture

12943

80336

1.79

307.65

3.4

2.8

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7466

33765

2.35

307.65

3.0

2.5

20.99

23.59

49.34

6520

28954

(3022313) Gas panel - Capillary blood

3245

10063

3.23

307.65

3.8

3.7

—

(3018095) Leukocytes [#/volume] in Urine

14006

96992

1.57

307.65

4.2

3.5

83.46

83.37

e6/l

0.00

10112

66411

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

32267

272896

1.83

307.65

17.3

11.2

86.07

85.51

ml/min/173m2

3.90

27524

223733

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

32613

274037

1.95

307.65

4.8

3.6

1.59

1.25

mmol/l

307.65

30459

254920

(40760892) CBC W Ordered Manual Differential panel - Blood

19310

135165

1.71

307.65

6.9

6.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5471

26790

2.08

307.65

8.7

7.4

5.31

5.05

kpa

55.86

5252

25611

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1668

5394

3.00

307.65

2.3

139.67

101.52

ug/min

2.19

1041

3260

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

30100

228281

2.24

307.65

5.1

3.9

14.58

14.61

pmol/l

1.16

28036

209804

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10857

71801

1.60

307.65

1.7

1.6

1.68

1.34

mmol/l

147.87

9196

61063

(3022948) Iron [Moles/volume] in Serum or Plasma

8528

40029

2.30

307.65

3.0

2.4

12.59

14.32

umol/l

3.10

8001

37432

(3024354) Oxygen [Partial pressure] in Venous blood

3891

17843

2.18

307.65

4.1

3.3

4.77

4.65

kpa

2.72

3761

17267

(3021960) Folate [Moles/volume] in Serum or Plasma

11025

56228

2.20

307.65

1.8

1.5

20.13

20.44

nmol/l

1.26

9812

48483

(3019069) Monocytes/100 leukocytes in Blood

19130

135255

1.68

307.65

7.0

6.3

8.06

8.43

55.44

18070

127209

(3019198) Lymphocytes [#/volume] in Blood

20800

148160

1.73

307.65

6.6

5.9

2.02

1.94

e9/l

9.20

18607

132363

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

33509

276465

2.38

307.65

6.0

4.0

6.34

5.79

mmol/l

307.65

31363

255527

(3009261) Glucose [Presence] in Urine by Test strip

19250

143699

1.54

307.65

4.3

3.4

0.01

0.00

estimate

0.58

3788

26663

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

19319

113975

2.23

307.65

3.0

2.2

70.36

865.84

nmol/l

0.50

17930

103930

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11664

78161

1.59

307.65

2.3

2.1

193.09

202.45

u/l

0.50

10969

73539

(3023368) Bacteria identified in Blood by Culture

11834

65958

2.01

307.65

4.8

4.1

—

(3006315) Basophils [#/volume] in Blood

20402

143463

1.75

307.65

6.5

5.9

0.04

e9/l

5.55

17831

125318

(3024561) Albumin [Mass/volume] in Serum or Plasma

19999

111308

2.49

307.65

5.4

4.7

35.49

36.02

g/l

36.52

18884

103437

(3001122) Ferritin [Mass/volume] in Serum or Plasma

20457

131914

2.02

307.65

3.9

2.8

106.95

110.44

ug/l

1.36

19282

123485

(3012544) pH of Venous blood

4849

22663

2.17

307.65

4.7

4.0

7.37

7.38

0.68

153

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

33331

256424

3.09

307.65

8.6

4.9

42.38

38.67

mmol/mol

307.65

31715

239187

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

33563

270379

2.67

307.65

6.2

4.6

2.10

2.07

mu/l

0.11

31630

251054

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14876

95854

1.77

307.65

4.3

3.1

50.06

60.44

ng/l

0.52

9723

58250

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15960

93085

2.07

307.65

3.4

3.2

32.84

32.61

u/l

0.14

15144

88480

(3003396) Base excess in Arterial blood by calculation

5464

26783

2.08

307.65

8.7

7.4

1.37

0.93

mmol/l

11.17

4476

21264

(3021601) Nitrite [Presence] in Urine by Test strip

19057

142328

1.53

307.65

5.8

4.5

0.00

estimate

0.62

4065

27262

(3020682) Albumin/Creatinine [Ratio] in Urine

15997

73421

2.84

307.65

4.5

3.8

11.73

8.93

mg/mmol

8.31

10991

45863

(3042936) Bacteria identified in Isolate by Culture

6956

36893

1.95

307.65

2.4

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12620

63036

2.34

307.65

3.5

2.8

1203.19

1157.83

ng/l

0.54

10447

53407

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10335

67019

1.62

307.65

2.5

2.2

—

(3009343) pH of Capillary blood

4322

14156

3.12

307.65

3.9

3.5

7.41

7.42

5.26

502

1920

(3006504) Eosinophils/100 leukocytes in Blood

19029

134509

1.68

307.65

6.6

6.0

2.78

2.85

3.80

17946

126254

(3022096) Basophils/100 leukocytes in Blood

18386

130077

1.65

307.65

6.7

6.1

0.64

0.69

34.06

17262

121668

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

34505

294122

2.38

307.65

19.7

12.2

21.23

22.30

mg/l

8.54

31097

226971

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4359

14346

3.11

307.65

3.9

3.5

5.28

5.10

kpa

34.03

4150

13593

(3035350) Ketones [Presence] in Urine by Test strip

19119

142194

1.54

307.65

4.3

3.4

0.00

estimate

0.04

4250

28310

(3002030) Lymphocytes/100 leukocytes in Blood

19508

139950

1.65

307.65

6.8

6.0

27.36

28.79

70.56

18482

131970

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5096

23516

2.20

307.65

2.4

2.3

0.22

g/l

0.48

4739

22002

(3019060) Gas panel - Arterial blood

3390

14934

2.25

307.65

5.2

4.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

9098

42471

2.34

307.65

2.0

1.7

1207.73

1160.65

nmol/l

4.96

7352

32203

(3027801) Oxygen [Partial pressure] in Arterial blood

5469

26774

2.08

307.65

8.7

7.4

11.10

13.01

kpa

161.20

5235

25591

(3019550) Sodium [Moles/volume] in Serum or Plasma

34925

293874

2.84

307.65

22.5

13.4

139.66

139.65

mmol/l

0.35

34403

286372

(3018010) Neutrophils/100 leukocytes in Blood

19261

137895

1.65

307.65

6.5

5.8

58.41

56.60

96.11

18227

129976

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5873

24943

2.44

307.65

2.1

2.2

345.20

379.64

nmol/l

32.09

5333

23111

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4182

13671

3.12

307.65

3.8

3.5

1.81

1.55

mmol/l

3.88

3140

9967

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9055

40253

2.48

307.65

3.4

3.6

0.82

mmol/l

1.48

8561

37763

(3026782) Osmolality of Urine

8547

52175

1.70

307.65

3.3

2.7

557.26

538.82

mosm/kgh2o

8.97

7394

44686

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1628

4812

3.28

307.65

1.9

2.2

1.05

0.79

nmol/l

25.58

1301

4096

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3851

17988

2.13

307.65

4.5

3.9

101.46

85.66

ng/l

15.46

3349

15773

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2779

8978

3.07

307.65

4.0

3.8

24.83

24.72

mmol/l

1.19

2611

8332

(3013115) Eosinophils [#/volume] in Blood

20973

148403

1.75

307.65

6.9

6.1

0.20

0.19

e9/l

27.42

18605

131435

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4728

21878

2.18

307.65

4.7

4.0

5.96

5.81

kpa

17.28

4592

21246

(3003458) Phosphate [Moles/volume] in Serum or Plasma

8080

30933

2.86

307.65

6.2

6.1

1.07

1.04

mmol/l

29.19

7683

28926

(3037467) Urinalysis macro (dipstick) panel - Urine

26140

198580

1.80

307.65

5.0

4.0

—

(1002224) Polysomnography panel

2960

12037

2.43

307.65

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

26050

200540

1.74

307.65

4.0

2.9

56.38

43.13

u/l

82.56

24530

189151

(3023103) Potassium [Moles/volume] in Serum or Plasma

34955

294794

2.82

307.65

22.7

13.5

3.96

3.95

mmol/l

25.40

34391

286679

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13956

85769

1.85

307.65

2.9

2.5

52.45

62.95

u/l

7.07

12944

79338

(3009508) Creatinine [Moles/volume] in Urine

16284

78615

2.68

307.65

3.6

3.2

7.94

7.91

mmol/l

0.06

13879

67318

(3002032) Base excess in Venous blood by calculation

4684

21845

2.16

307.65

4.8

4.0

2.00

1.79

mmol/l

3.10

4016

18632

(3044640) Blood type and Crossmatch panel - Blood

13727

88299

1.73

307.65

2.5

2.3

—

(3001604) Monocytes [#/volume] in Blood

20348

143173

1.74

307.65

6.5

5.9

0.60

0.57

e9/l

64.00

17813

125195

(3000991) Gas panel - Venous blood

4113

20504

2.00

307.65

10.3

8.5

—

(3030467) Casts [#/volume] in Urine by Automated count

11104

74010

1.59

307.65

3.5

3.0

0.47

0.38

e6/l

3.81

8614

55425

(3033658) Prothrombin time (PT) actual/Normal

10777

69397

1.65

307.65

4.5

3.8

92.73

92.51

0.39

10448

67602

(40768797) Stomach Pathology biopsy report

6673

37096

1.84

307.65

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1243

1365

8.83

307.65

4.1

2.6

40.93

16.88

mu/l

44.37

1192

1266

(3007853) Bacteria identified in Skin by Aerobe culture

6554

31695

2.15

307.65

2.0

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

19372

135788

1.71

307.65

2.8

2.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

24628

158247

2.37

307.65

6.2

4.4

7.10

6.55

mmol/l

207.34

23066

146181

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

12736

64714

2.29

307.65

2.6

2.1

3.15

2.79

mg/l

47.60

11292

55288

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10917

61857

1.93

307.65

2.0

1.7

1.03

1.12

mg/l

2.44

8496

46481

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

18542

103685

2.36

307.65

2.4

1.8

94.71

97.50

pmol/l

13.00

11101

53809

(3016502) Oxygen saturation in Arterial blood

4879

23929

2.06

307.65

9.1

7.8

94.74

96.04

37.52

4729

23014

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

10010

53447

2.04

307.65

2.0

1.6

30731890.27

39295533.06

pmol/l

0.74

8558

44914

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

21639

140080

2.08

307.65

5.9

6.1

10.63

11.02

umol/l

4.44

20524

132613

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

29299

213968

2.34

307.65

8.4

7.2

81.02

76.04

u/l

59.96

28031

201953

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20434

128801

2.09

307.65

8.2

6.4

1.21

1.22

mmol/l

31.17

17655

109561

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6505

35238

1.89

307.65

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

34015

290154

2.16

307.65

5.9

4.4

2.66

2.83

mmol/l

223.24

32053

271061

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

33558

286182

2.03

307.65

5.4

4.0

4.46

4.75

mmol/l

307.65

31729

268748

(3020779) Urea [Moles/volume] in Serum or Plasma

4492

21109

2.14

307.65

9.2

7.7

10.69

8.87

mmol/l

46.11

4281

20200

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7996

36570

2.35

307.65

2.9

2.4

2.47

2.36

g/l

48.42

7416

33888

(3015377) Calcium [Moles/volume] in Serum or Plasma

13815

88701

1.74

307.65

3.0

3.4

2.34

2.35

mmol/l

21.35

12223

78912

(3002582) Erythrocytes [#/volume] in Urine

12106

80831

1.61

307.65

3.6

3.1

70.09

81.94

e6/l

0.45

9462

61139

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1113

2706

3.96

307.65

1.2

31.11

27.00

nmol/l

0.27

(3018418) pH of Serum or Plasma

12083

76423

1.72

307.65

4.8

4.0

7.40

1.11

2348

14575

(3026493) Urate [Moles/volume] in Serum or Plasma

13642

68969

2.36

307.65

2.9

2.5

3569.76

3623.34

umol/l

0.06

12040

61284

(3031040) Bacteria [#/volume] in Urine by Automated count

24738

188658

1.69

307.65

5.3

4.0

1295.87

1388.29

e6/l

0.11

406

2340

(3013650) Neutrophils [#/volume] in Blood by Automated count

22490

165263

1.71

307.65

9.4

9.0

4.54

4.00

e9/l

228.31

19808

145098

(3013707) Erythrocyte sedimentation rate by Westergren method

27165

212693

1.74

307.65

4.8

3.9

15.26

10.68

mm/h

307.65

25401

198174

(3014111) Lactate [Moles/volume] in Serum or Plasma

4155

21331

1.94

307.64

8.9

7.1

1.43

1.33

mmol/l

7.40

4044

20834

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1418

4550

3.01

305.11

3.5

3.1

—

(3021589) Normoblasts [#/volume] in Blood

17253

127910

1.50

303.16

11.4

8.9

0.00

e9/l

2.89

14214

105235

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

6384

37954

1.70

289.27

1.9

1.7

1.47

1.41

7.53

5587

33808

(3037522) Nuclear Ab [Titer] in Serum

6770

40965

1.68

286.85

1.4

475.64

555.74

titre

3.04

1274

8313

(3004119) Hemoglobin [Mass/volume] in Venous blood

2988

13975

2.10

286.15

4.2

3.4

130.27

129.70

g/l

0.65

2914

13649

(3027945) Reticulocytes/100 erythrocytes in Blood

4798

26385

1.82

285.05

2.6

1.95

1.73

33.09

4215

23560

(3027273) Bicarbonate [Moles/volume] in Venous blood

2473

10770

2.24

283.52

4.1

3.3

25.40

25.21

mmol/l

1.69

2404

10430

(3000850) Epithelial cells [#/volume] in Urine

8641

55729

1.60

283.10

2.9

2.5

7.50

5.97

e6/l

16.16

7769

49701

(3044889) 12 lead EKG panel

24145

193071

1.50

282.98

4.2

3.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

35414

312350

2.31

278.70

13.3

9.5

30.29

25.93

u/l

196.24

34614

302336

(3020564) Creatinine [Moles/volume] in Serum or Plasma

35243

310404

2.23

275.26

22.0

13.8

77.45

73.90

umol/l

42.70

35235

310286

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2313

9925

2.27

274.53

5.0

3.7

50.22

48.81

1.82

2282

9823

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5402

31139

1.74

272.13

2.8

2.7

7.92

8.00

umol/l

0.09

4555

26883

(36304419) Bacteria [Presence] in Urine

10685

72989

1.53

268.83

3.5

2.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4787

26827

1.78

265.48

1.9

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

297

265

10.63

263.79

1.0

71.87

92.01

ug/l

8.16

263

207

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2668

12356

2.11

261.34

11.0

9.7

24.65

24.22

mmol/l

8.12

2571

12006

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4790

27008

1.77

259.70

1.9

1.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1253

4160

2.90

253.15

1.1

43.83

2910.99

iu/ml

0.67

281

968

(3007164) IgA [Mass/volume] in Serum or Plasma

8907

59252

1.54

249.58

1.5

1.4

2.53

2.29

g/l

22.99

5485

36808

(3021901) Oxygen saturation in Capillary blood

1234

4106

2.89

248.27

3.2

2.7

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

803

2074

3.70

244.13

1.5

1.3

1.71

1.35

nmol/l

12.99

740

1862

(3028626) Oxygen [Partial pressure] in Capillary blood

1493

5549

2.60

242.60

3.6

3.3

8.30

8.54

kpa

6.13

1465

5410

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10029

68976

1.50

238.35

1.3

1.51

1.64

u/ml

0.48

2757

19091

(4146454) Self-monitoring of blood glucose

828

2243

3.53

234.45

2.7

2.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3458

18236

1.86

232.14

1.7

1.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2291

10534

2.12

227.70

3.6

3.0

0.65

0.00

2281

10495

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3489

18559

1.85

227.67

3.1

2.7

170.20

173.66

ng/l

0.19

3087

16848

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2329

10781

2.10

227.42

3.7

3.0

1.43

1.29

5.74

2316

10726

(40761511) CBC panel - Blood by Automated count

34904

309125

1.97

221.14

18.6

11.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2927

14946

1.92

216.35

11.3

9.4

0.65

0.68

4.59

2906

14867

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2928

14972

1.91

215.48

11.2

9.3

1.46

1.37

3.98

2905

14885

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2464

11879

2.02

215.14

5.1

4.5

24.18

24.10

mmol/l

0.56

2409

11646

(3014007) Fractional oxyhemoglobin in Arterial blood

2938

15051

1.91

214.99

11.3

9.4

93.09

94.17

17.56

2926

14998

(1616796) Gas panel - Central venous blood

1412

5411

2.51

214.98

4.7

3.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2868

14615

1.92

213.17

8.4

7.1

24.97

24.50

mmol/l

7.80

2759

13886

(40758558) Short blood count panel - Blood

10160

71403

1.47

211.59

6.8

6.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2979

15434

1.89

210.40

8.7

7.2

25.10

24.70

mmol/l

5.89

2953

15306

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

14664

110475

1.41

207.83

4.6

3.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

8286

56305

1.50

202.92

1.8

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

3508

19321

1.78

202.86

2.6

79.16

69.08

e9/l

38.49

2621

14466

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3486

19223

1.78

200.65

3.1

3.4

4.48

4.52

pmol/l

1.71

3058

17284

(3020630) Protein [Mass/volume] in Serum or Plasma

3478

19170

1.78

200.50

2.1

2.6

66.70

66.69

g/l

0.03

3164

17594

(3028026) IgM [Mass/volume] in Serum or Plasma

3060

16251

1.84

199.44

1.7

1.9

1.17

1.33

g/l

8.24

2792

14906

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5180

31821

1.62

199.08

5.1

4.1

29.83

32.54

65.37

4072

22453

(3019225) pH of Specimen

4213

24614

1.69

196.97

4.6

4.0

—

(3034770) Mitochondria Ab [Titer] in Serum

1735

7576

2.21

195.90

1.2

1085.79

915.22

titre

0.41

230

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7362

49191

1.51

194.40

1.3

9.27

11.29

u/ml

1.88

2834

19727

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2832

14793

1.87

194.35

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1931

8829

2.12

193.98

2.3

2.0

2.08

2.11

ug/l

0.04

1722

7819

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6990

46217

1.52

193.97

2.7

3.0

2.45

2.44

mmol/l

1.94

5981

40567

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7707

52117

1.49

191.59

1.3

33.61

33.03

iu/ml

0.05

2217

16913

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2672

13782

1.89

190.59

1.8

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

7285

48775

1.50

189.88

4.1

3.4

344.20

519.29

ng/l

2.62

5234

34498

(3005719) IgG [Mass/volume] in Serum or Plasma

3726

21268

1.72

189.35

2.4

2.7

10.56

10.50

g/l

0.37

3401

19534

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6842

45247

1.52

189.06

2.9

2.6

1.33

1.12

e6/l

1.84

3896

25256

(3027923) C peptide [Moles/volume] in Serum or Plasma

531

1230

4.11

187.89

2.0

1.5

1.58

1.14

nmol/l

11.59

414

972

(3029937) Albumin [Presence] in Urine by Test strip

10550

76052

1.43

186.73

4.8

3.7

0.00

estimate

0.67

3844

26425

(3007566) Smooth muscle Ab [Titer] in Serum

1732

7718

2.17

185.72

1.2

1.3

118.31

123.40

titre

0.10

166

712

(4200892) Spirometry reversibility

3438

19286

1.75

185.71

1.5

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4667

28406

1.62

185.12

3.5

4.4

236.93

239.98

u/l

0.61

4401

26980

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6415

42178

1.52

181.23

3.1

2.8

4.91

2.95

e6/l

8.50

3488

22358

(3017143) Hepatitis C virus Ab [Presence] in Serum

5898

38183

1.54

178.75

1.7

1.6

—

(3020891) Body temperature

1957

9301

2.03

176.84

5.7

4.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1662

7438

2.15

176.11

3.4

3.3

0.35

u/ml

0.12

963

4202

(3000494) Fungus identified in Specimen by Culture

5133

32460

1.57

172.19

1.5

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

1997

9749

1.98

167.13

1.4

8.60

10.39

u/l

9.76

1629

8005

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1306

5507

2.28

159.98

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

1721

8095

2.05

159.66

4.6

4.3

1.44

1.36

mmol/l

1.85

1688

7955

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5966

39641

1.50

157.70

2.3

2.2

30.19

29.63

9.05

5773

38466

(3010421) pH of Blood

1462

6495

2.16

157.57

5.4

3.5

7.41

7.42

4.79

1343

5925

(3027315) Oxygen [Partial pressure] in Blood

1317

5623

2.25

156.56

5.5

3.6

8.59

8.80

kpa

4.12

1292

5498

(3013290) Carbon dioxide [Partial pressure] in Blood

1311

5587

2.25

156.54

5.4

3.6

5.17

4.96

kpa

15.73

1286

5463

(3013139) Helicobacter pylori Ag [Presence] in Stool

3320

19293

1.68

156.23

1.2

—

(3012501) Base excess in Blood by calculation

1310

5586

2.25

156.20

5.4

3.6

2.95

2.35

mmol/l

8.30

910

3675

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4151

25570

1.59

154.60

2.7

2.5

50.07

45.47

u/l

0.14

3461

21987

(3021387) Prolactin [Units/volume] in Serum or Plasma

2437

13069

1.81

152.29

1.7

1.6

305.44

315.24

mu/l

0.61

2179

11771

(3004588) Protein electrophoresis panel - Serum or Plasma

2788

15558

1.74

152.01

1.9

2.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1456

6611

2.12

148.24

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3482

20750

1.64

148.18

4.8

3.7

1.22

1.23

mmol/l

20.55

3096

18091

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2167

11334

1.85

146.74

1.4

1.5

11.28

13.10

u/ml

0.35

307

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2065

10660

1.87

145.71

1.8

1.63

1.48

g/l

10.19

1767

9196

(3023183) Ammonium ion [Moles/volume] in Plasma

1210

5140

2.26

145.50

3.5

2.7

35.70

33.73

umol/l

1.95

1122

4674

(3011397) Hemoglobin [Presence] in Urine by Test strip

9066

65935

1.39

144.84

4.1

3.4

—

(3008037) Lactate [Moles/volume] in Venous blood

1119

4658

2.30

141.14

3.9

2.9

1.64

1.54

mmol/l

2.74

1100

4551

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2208

11764

1.81

140.64

2.0

1.6

5.12

3.62

mg/l

6.73

2039

8087

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1892

9610

1.90

140.24

5.8

4.9

1.78

1.69

1.92

1803

8968

(3019150) Specific gravity of Urine by Refractometry

8489

61426

1.39

138.76

4.6

3.6

1.02

kg/l

0.12

1278

9275

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4120

25963

1.55

137.91

4.1

3.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8729

63690

1.38

134.98

1.8

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1017

4151

2.34

134.21

1.7

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1258

5620

2.15

133.41

2.6

2.1

131.34

131.02

g/l

0.17

950

4066

(40767503) Oxygen content in Capillary blood by calculation

1184

5165

2.20

133.33

3.2

2.4

16.55

16.64

0.31

703

2594

(3041096) Erythrocytes [Presence] in Urine by Automated

10537

79311

1.35

133.23

3.9

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

9201

67850

1.37

132.74

2.0

1.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1838

9440

1.88

131.46

6.0

5.0

0.86

0.91

6.10

1755

8817

(3037121) Protein [Mass/volume] in Urine

1725

8682

1.91

131.29

3.0

3.3

0.37

0.32

g/l

1.51

831

3862

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2821

16417

1.67

130.95

2.5

2.2

6205.62

6114.68

u/l

0.05

1097

6667

(3038515) Glucose [Moles/volume] in Venous blood

1047

4375

2.29

130.81

4.0

2.9

7.83

7.41

mmol/l

4.02

1030

4287

(3010015) Selenium [Moles/volume] in Serum or Plasma

163

170

9.06

129.55

2.2

1.9

1.31

umol/l

0.00

155

147

(3002385) Erythrocyte distribution width [Ratio]

29653

258871

1.38

128.42

22.5

14.5

15.38

14.88

10.22

29364

254379

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

447

1222

3.47

124.77

1.7

1.6

2.97

9.60

nmol/l

0.79

370

1012

(3017181) Myelocytes/100 leukocytes in Blood

3677

23072

1.55

124.65

4.4

4.1

0.88

0.95

0.87

1306

7378

(3011985) Renin [Units/volume] in Plasma

898

3601

2.38

123.31

1.5

1.6

80.24

64.96

mu/l

1.10

797

3223

(3021440) Promyelocytes/100 leukocytes in Blood

3521

21971

1.56

122.20

4.4

4.1

0.09

0.12

2.37

1153

6309

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2342

13215

1.71

121.74

12.6

9.6

—

(3043409) Potassium [Moles/volume] in Arterial blood

1440

7002

1.97

121.19

5.1

4.5

3.90

3.86

mmol/l

2.00

1426

6948

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

557

1773

2.99

121.03

1.3

5.50

5.16

umol/l

1.15

516

1638

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1736

8992

1.86

120.70

1.6

183.87

313.16

titre

1.81

351

(3005322) IgE [Units/volume] in Serum or Plasma

3199

19815

1.57

114.28

1.3

271.17

226.96

u/ml

0.94

2984

18361

(3048689) Calprotectin [Mass/mass] in Stool

5561

38547

1.42

113.65

2.4

136.62

124.30

ug/g

1.82

4427

30388

(3028717) Thiamine [Mass/volume] in Blood

161

199

7.64

111.73

1.3

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3353

21113

1.54

111.16

4.0

3.9

0.61

0.69

1.26

1136

6397

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1972

10923

1.74

109.26

1.5

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3545

22722

1.52

108.07

1.2

138.53

144.93

iu/ml

0.35

1287

8740

(3020876) Protein [Mass/time] in 24 hour Urine

680

2558

2.53

107.23

2.6

1.65

1.27

g/24h

2.91

365

1302

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1907

10576

1.73

105.10

2.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

1207

5798

1.99

105.02

4.5

3.7

—

(3025159) Blasts/100 leukocytes in Blood

3306

21006

1.53

104.82

4.5

4.2

0.18

0.31

0.61

943

5405

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

811

3340

2.31

104.74

1.4

467.70

370.86

pmol/l

0.34

717

2917

(3027456) Digoxin [Moles/volume] in Serum or Plasma

812

3353

2.31

104.22

3.2

3.0

0.81

nmol/l

0.07

635

2529

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1150

5465

2.01

103.14

1.4

1.3

17.41

26.91

u/l

27.73

938

4527

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3139

19821

1.54

102.31

2.5

2.2

6.36

7.64

ug/l

2.39

2653

17483

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1595

8480

1.80

101.59

2.4

2.3

575.99

512.22

ug/l

0.16

1494

7864

(3024928) Oxygen saturation in Venous blood

1079

5072

2.03

99.72

4.1

3.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1357

6914

1.88

99.07

2.3

3.5

38.29

41.21

mg/l

0.50

1027

5630

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1746

9601

1.75

99.06

1.9

1.8

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1357

6924

1.88

98.62

2.3

3.5

56.18

57.63

mg/l

0.06

1033

5635

(3035285) Chloride [Moles/volume] in Venous blood

654

2514

2.47

98.52

2.7

2.2

105.73

105.68

mmol/l

0.11

649

2493

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1325

6712

1.89

98.47

2.3

3.5

2.44

3.70

ratio

0.49

106

530

(3041354) Potassium [Moles/volume] in Venous blood

654

2516

2.47

98.35

2.7

2.2

4.06

4.03

mmol/l

0.92

649

2495

(3033705) Calcium.ionized [Moles/volume] in Venous blood

644

2465

2.48

97.90

2.8

2.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

266

603

4.17

97.02

1.7

1.2

17.43

16.85

umol/l

1.00

240

536

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1399

7250

1.85

96.79

1.4

1.5

15.61

14.30

iu/ml

0.10

167

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1450

7601

1.83

96.68

1.4

285.75

278.52

ug/g

0.62

800

4327

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2048

11845

1.66

96.39

2.0

38.73

39.46

u/l

0.88

1818

10652

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1056

5018

2.01

94.67

1.2

96.47

138.91

titre

0.43

110

(3003694) ABO and Rh group [Type] in Blood

11255

88705

1.28

93.60

1.6

1.5

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

613

2345

2.48

93.31

1.9

2.2

18.83

19.44

nmol/l

0.86

570

2241

(3024666) Lithium [Moles/volume] in Serum or Plasma

508

1774

2.72

93.07

13.4

11.7

0.61

0.63

mmol/l

0.72

464

1633

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1493

7991

1.79

92.87

1.9

1.7

33.63

43.56

nmol/l

37.91

1446

7804

(3009542) Hematocrit [Volume Fraction] of Blood

36104

330832

1.83

92.05

29.5

18.0

40.30

40.49

2.47

34497

312379

(40761535) Cells panel - Urine sediment

3246

21125

1.49

91.07

3.9

3.3

—

(3007461) Platelets [#/volume] in Blood

36123

331181

1.82

90.06

29.3

18.0

263.82

255.51

e9/l

107.11

35565

323278

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1739

9814

1.70

89.67

2.0

1.7

—

(3004775) Volume in Urine collected for unspecified duration

501

1778

2.67

88.96

2.3

726.65

662.57

1.99

344

1256

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2226

13455

1.59

87.44

3.0

2.6

0.37

0.25

e6/l

2.54

2176

13028

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1362

7224

1.80

87.27

3.8

3.9

1.79

1.42

mg/l

34.55

1247

6718

(3035941) MCH [Entitic mass]

36129

331432

1.81

87.15

29.1

17.9

29.78

30.25

307.65

35833

327446

(3025941) Bacteria identified in Stool by Culture

2734

17320

1.52

87.15

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

784

3436

2.17

87.11

1.6

1.5

—

(3024731) MCV [Entitic volume]

36129

331475

1.80

86.46

29.2

17.9

90.05

90.68

120.48

35834

327475

(3026361) Erythrocytes [#/volume] in Blood

36130

331504

1.80

86.18

29.3

17.9

4.56

4.51

e12/l

78.44

35501

322816

(3017446) Testosterone [Moles/volume] in Serum or Plasma

3025

19618

1.49

86.11

2.8

2.1

8.87

12.33

nmol/l

96.51

2678

17753

(3010813) Leukocytes [#/volume] in Blood

36132

331536

1.80

86.05

29.3

18.0

7.39

6.64

e9/l

307.65

35494

322781

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

679

2821

2.29

85.92

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

36135

331625

1.80

85.20

29.5

18.0

134.81

135.68

g/l

24.77

35854

327656

(3000492) Spirometry study

4238

29344

1.41

84.93

1.5

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1595

8935

1.71

84.43

1.6

1.8

0.26

0.23

g/l

34.25

1515

8482

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1390

7498

1.77

84.10

2.0

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

24380

211324

1.25

83.24

3.6

3.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

725

3144

2.19

82.72

7.2

6.3

11.36

11.33

mg/l

0.05

662

2902

(3023323) Follitropin [Units/volume] in Serum or Plasma

2811

18128

1.50

82.09

1.4

1.3

20.30

27.76

iu/l

39.54

2359

15710

(3022145) Colonoscopy Study observation

4485

31567

1.38

81.26

1.4

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

821

3769

2.07

80.87

1.2

1.3

0.19

0.25

nmol/l

0.51

228

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1621

9233

1.68

80.60

1.6

1.8

1.31

1.15

g/l

79.07

1546

8795

(3028271) Lactate [Moles/volume] in Capillary blood

841

3904

2.05

80.39

2.4

1.8

1.76

1.72

mmol/l

0.56

825

3808

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

215

480

4.23

80.09

1.5

1.4

7.64

5.57

nmol/l

0.56

205

458

(3040151) Glucose [Moles/volume] in Capillary blood

648

2721

2.26

79.97

9.0

7.9

8.16

7.11

mmol/l

2.71

538

2217

(3000330) Specific gravity of Urine by Test strip

2074

12585

1.58

79.94

3.9

3.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1248

6637

1.80

79.19

1.5

1.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

805

3711

2.06

78.41

1.1

1.51

1.49

g/l

0.33

718

3382

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

793

3645

2.07

77.86

1.2

1.3

34.95

33.96

u/l

0.06

679

3189

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

816

3795

2.05

77.61

1.2

1.3

1.08

1.27

nmol/l

0.12

786

3653

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

753

3403

2.11

77.33

1.2

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1067

5454

1.87

76.97

2.1

1.8

152.34

193.48

pmol/l

29.49

992

5202

(3028707) Methadone [Presence] in Urine by Screen method

1137

5956

1.82

75.82

2.6

2.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

1023

5204

1.87

74.91

2.3

3.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

937

4639

1.92

74.54

1.8

1.6

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

397

1385

2.72

72.97

1.8

1.4

16.72

27.14

umol/l

13.46

379

1319

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1535

8844

1.66

72.94

1.9

2.3

7.76

7.27

g/l

22.59

1385

8031

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1533

8832

1.66

72.86

1.9

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1531

8824

1.66

72.65

1.9

2.3

3.99

3.65

g/l

16.64

1381

8019

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4481

32107

1.36

71.86

7.9

6.1

—

(3017732) Neutrophils [#/volume] in Blood

3010

20200

1.44

71.15

3.0

2.6

5.11

4.76

e9/l

0.82

2417

16702

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1012

5215

1.85

71.14

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1011

5213

1.85

70.93

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1134

6083

1.78

69.83

1.8

1.6

14061.82

12810.96

e6/l

0.37

804

4463

(3022806) Fractional oxyhemoglobin in Capillary blood

697

3203

2.07

68.49

2.3

1.7

89.24

90.26

4.52

686

3153

(3023511) Choriogonadotropin [Units/volume] in Urine

1445

8351

1.65

67.80

1.4

1.3

—

(3010838) Calcium [Moles/time] in 24 hour Urine

948

4870

1.85

67.30

2.1

1.9

5.19

5.25

mmol/24h

0.19

843

4367

(3017569) Oxygen content in Arterial blood

304

960

3.00

67.18

2.1

2.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

807

3937

1.95

67.06

6.1

5.1

360.10

374.08

umol/l

1.90

713

3410

(3052851) Hemolysis interference index of Serum or Plasma

1388

7967

1.66

66.86

3.1

3.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1098

5922

1.77

66.35

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1423

8257

1.65

65.70

1.8

2.3

10.11

10.13

g/l

0.06

1264

7404

(3016750) Collection duration of Urine

375

1347

2.64

65.14

2.1

2.2

496.62

501.21

min

0.37

270

1038

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1486

8762

1.62

64.32

2.6

2.7

3.94

3.55

g/l

18.86

1407

8353

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1315

7528

1.67

63.97

2.2

2.1

10.99

10.70

mg/l

0.62

1222

7059

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

983

5224

1.79

62.46

1.5

1.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1913

12051

1.52

61.98

1.3

1.2

0.59

0.93

u/ml

1.08

192

1016

(3003129) Base excess in Capillary blood by calculation

203

526

3.65

61.66

1.6

1.7

0.71

0.59

mmol/l

0.16

194

492

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1091

6002

1.73

61.49

1.6

1.7

—

(40761536) Microorganisms panel - Urine sediment

3533

24984

1.37

60.95

4.7

3.6

—

(36660697) Celiac disease serology panel - Serum

3495

24708

1.37

60.38

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1417

8388

1.61

60.32

1.9

2.3

3.02

2.90

g/l

4.54

1269

7581

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

454

1855

2.32

59.84

18.4

18.0

3058.67

2776.48

nmol/l

0.06

437

1777

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

437

1758

2.36

59.69

12.9

13.0

825.14

1399.68

nmol/l

0.51

419

1703

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

337

1200

2.66

59.60

2.2

152.44

143.90

umol/l

0.15

174

598

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

495

2103

2.23

59.49

1.1

294.44

429.33

mg/l

0.48

423

1917

(3011288) Drugs identified in Urine by Screen method

1577

9611

1.57

59.32

2.6

3.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

801

4069

1.87

58.91

1.3

—

(21494755) Public health laboratory ask at order entry panel

2827

35928

0.72

58.67

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

860

4498

1.82

57.62

1.6

1.3

7.34

6.90

mmol/l

4.95

762

4036

(3036489) Thrombin time

1742

10949

1.52

56.96

2.1

2.2

21.04

21.37

1.31

1470

9436

(3012565) Volume of 24 hour Urine

348

1293

2.55

56.50

2.2

1917.43

2019.12

1.03

311

1172

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1288

7578

1.62

56.18

2.0

2.4

0.49

0.80

g/l

4.65

1112

6579

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

308

1080

2.70

56.18

2.0

2.1

181.76

91.43

ug/min

0.52

232

(3044941) Cell count panel - Synovial fluid

763

3877

1.87

56.08

1.5

1.4

—

(40768441) Liver Pathology biopsy report

457

1927

2.25

55.96

1.4

—

(3021788) Differential panel - Synovial fluid

880

4694

1.78

55.22

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1041

5837

1.70

54.74

1.6

1.7

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

330

1215

2.57

54.61

1.9

1.8

1.86

1.97

umol/l

1.76

309

1141

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3426

24569

1.34

53.57

1.4

1.5

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

460

1986

2.19

53.19

1.1

1.3

—

31.25

u/ml

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

629

3052

1.96

53.16

2.2

2.0

24.44

25.29

mg/l

0.14

200

796

(3019977) pH of Arterial blood

329

1228

2.54

52.95

2.8

2.5

7.41

7.43

1.67

132

403

(3025468) Yersinia sp identified in Specimen by Organism specific culture

682

3405

1.90

52.94

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

683

3413

1.90

52.88

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1161

6762

1.64

52.74

1.9

2.3

0.01

0.03

g/l

2.71

1058

6210

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

681

3411

1.90

52.35

1.4

—

(40768804) Tissue Pathology biopsy report

14124

119052

1.19

52.07

2.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3085

21868

1.36

51.99

3.0

2.5

65.27

69.77

ml/min/173m2

5.91

1455

8216

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1177

6906

1.62

51.90

1.8

2.2

36.87

38.25

g/l

11.83

1029

6083

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

698

3537

1.87

51.77

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

786

4133

1.81

51.76

1.2

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

683

3457

1.88

50.84

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

882

4829

1.74

50.57

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

619

3049

1.93

50.07

1.4

9.13

7.77

mmol/l

10.78

594

2953

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1890

12397

1.46

49.93

1.1

9.00

10.11

u/ml

0.05

192

(3047181) Lactate [Moles/volume] in Blood

1312

7974

1.57

49.88

7.3

5.5

1.40

1.27

mmol/l

5.96

1183

7057

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

302

1126

2.54

48.76

2.0

1.8

27.34

29.20

umol/l

2.25

292

1084

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

676

3458

1.86

48.69

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1992

13275

1.44

48.32

2.5

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1482

9334

1.51

47.89

1.7

1.8

—

(3000034) Microalbumin [Mass/volume] in Urine

485

2228

2.06

47.83

3.7

2.8

69.85

49.85

mg/l

0.87

367

1560

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1063

6239

1.62

46.81

1.9

2.3

0.00

g/l

0.08

962

5703

(3048929) Epstein Barr virus Ab [Presence] in Serum

1630

10524

1.48

46.65

1.2

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

750

4026

1.77

46.10

2.8

3.3

1.27

1.57

1.81

657

3615

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

788

4292

1.74

46.04

1.6

1.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1378

8620

1.52

45.97

2.5

2.6

191.40

181.06

4.22

1300

8163

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1479

9395

1.50

45.86

2.2

2.4

93.78

92.91

0.73

1408

9008

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5367

41614

1.25

45.47

2.1

2.0

—

(3020491) Glucose [Moles/volume] in Blood

453

2068

2.07

45.45

2.0

1.6

7.09

6.42

mmol/l

3.92

304

1578

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

500

2380

1.99

44.72

1.6

1.5

29.08

33.22

1.66

317

1482

(1001926) Buprenorphine [Presence] in Urine by Screen method

1677

11000

1.46

44.22

2.1

2.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1040

6159

1.61

44.14

1.9

2.3

0.00

g/l

-0.00

954

5690

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

847

4778

1.68

43.57

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

693

3709

1.77

43.06

1.4

—

(3037756) Immunofixation for Serum or Plasma

825

4649

1.69

42.61

1.3

1.8

—

(3022621) pH of Urine by Test strip

2550

18115

1.35

42.02

3.3

2.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

613

3188

1.82

41.93

1.6

58.62

54.73

1.48

390

2036

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

786

4406

1.69

41.41

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5858

46277

1.23

41.31

2.2

2.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1301

8252

1.50

40.61

1.5

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

763

4268

1.70

40.53

4.5

3.3

66.66

64.67

1.74

758

4251

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

605

3171

1.81

40.35

1.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

184

587

2.96

40.17

1.2

317.37

342.34

pmol/l

0.25

126

445

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

551

2820

1.85

39.71

1.2

61.61

62.24

u/l

0.07

500

2523

(3008898) HLA-B27 [Presence]

1705

11446

1.42

39.59

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

674

3671

1.74

39.44

2.7

2.6

360.15

583.60

u/ml

0.26

667

3621

(3019832) Treponema pallidum Ab [Presence] in Serum

5147

40413

1.23

38.17

1.8

1.7

—

(3044927) Protein electrophoresis panel - Urine

435

2088

1.97

38.07

1.3

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

627

3380

1.76

38.05

1.6

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2103

14740

1.36

37.71

1.5

1.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

261

1028

2.40

37.60

2.2

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

898

5350

1.59

37.21

2.2

2.1

5.99

6.36

umol/l

0.28

661

3893

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

740

4210

1.67

36.91

1.5

1.7

—

(3000012) Reticulocyte production index

584

3113

1.78

36.85

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

739

4209

1.67

36.70

1.5

1.7

—

(3036603) Volume of Urine

380

1766

2.04

36.44

1.6

2044.56

1984.05

0.54

370

1723

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1398

9189

1.45

36.41

1.7

1.6

1.50

6.19

iu/ml

1.01

302

1848

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

288

1206

2.26

36.06

1.5

1.4

437.70

695.83

mu/l

1.80

276

1148

(3001556) Androgen free Index in Serum or Plasma

121

322

3.55

35.55

1.3

1.1

—

(3006270) Folate [Moles/volume] in Blood

427

2092

1.93

35.25

1.2

1.1

389.62

377.57

nmol/l

0.56

339

1854

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

290

1238

2.21

34.68

1.5

1.4

73.07

72.78

0.12

278

1180

(3014271) Vancomycin [Susceptibility]

246

982

2.37

34.44

3.2

2.8

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

162

526

2.91

34.36

1.2

—

(3002256) Pathology report gross observation

4723

37141

1.23

34.18

1.2

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

795

4698

1.61

34.11

1.4

1.6

0.70

0.74

g/l

0.53

606

3570

(40768443) Skin Pathology biopsy report

1742

12038

1.38

34.08

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1309

8607

1.45

34.03

1.2

—

(3022689) Creatine [Moles/volume] in Urine

197

715

2.60

33.80

1.5

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1296

8527

1.45

33.57

1.2

—

(4034850) Laboratory test

1336

8846

1.44

33.45

10.6

8.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

332

1516

2.07

33.45

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

1307

8628

1.44

33.26

1.2

—

(3045424) Erythrocytes [Presence] in Urine

806

4809

1.59

33.22

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

327

1491

2.07

33.08

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

793

4720

1.59

33.02

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

614

3432

1.70

32.79

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

914

5634

1.54

32.66

4.6

3.1

24.94

25.94

mg/l

0.33

610

3450

(3002079) Sodium [Moles/time] in 24 hour Urine

294

1294

2.15

32.62

1.2

176.70

153.21

mmol/24h

4.03

294

1294

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

452

2317

1.85

32.51

1.2

176.62

178.73

titre

0.02

395

(3010144) Erythrocytes [#/volume] in Synovial fluid

456

2347

1.84

32.38

1.5

1.4

99008.38

99472.48

e6/l

0.01

332

1606

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1518

10345

1.40

32.28

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

2000

14241

1.34

32.25

2.1

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1220

7999

1.45

32.20

2.5

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1010

6380

1.50

32.18

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1005

6344

1.50

32.13

1.5

1.4

13.95

20.57

u/ml

1.45

120

(3016879) Cocaine [Presence] in Urine

1873

13214

1.35

32.12

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

729

4282

1.61

32.09

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

236

955

2.33

32.08

2.5

2.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

793

4756

1.58

31.99

1.3

1.2

4.17

3.85

u/ml

0.29

334

2116

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1597

10994

1.38

31.97

1.6

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

815

4923

1.57

31.88

1.3

1.2

3.61

3.39

u/ml

0.12

255

1702

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

448

2313

1.83

31.51

1.2

174.29

161.60

titre

0.05

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1092

7045

1.47

31.35

1.2

1.3

—

(3004451) EKG impression Narrative

252

1063

2.24

31.09

1.3

—

(3027008) Opiates [Presence] in Urine

2000

14341

1.33

30.73

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

2002

14375

1.33

30.46

2.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

265

1151

2.18

30.44

1.3

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

2113

15291

1.32

30.43

1.1

220.65

191.47

titre

0.14

402

(3023419) Bacteria identified in Sputum by Culture

626

3588

1.65

30.42

2.6

2.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

265

1152

2.17

30.38

1.3

1.5

—

(3039000) Anion gap in Blood

881

5480

1.53

30.22

8.7

6.6

11.45

11.16

mmol/l

1.71

808

4932

(3018572) Chloride [Moles/volume] in Blood

881

5481

1.53

30.19

8.7

6.6

105.09

105.28

mmol/l

0.64

808

4933

(37021550) Renin [Units/volume] in Plasma --upright

155

528

2.77

30.16

1.3

93.71

78.32

mu/l

0.29

111

405

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

423

2189

1.83

29.56

1.3

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

416

2147

1.83

29.33

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

416

2147

1.83

29.33

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

416

2147

1.83

29.33

1.4

1.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2282

16777

1.30

29.24

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

754

4573

1.56

29.01

1.1

124.51

117.57

6.64

673

4138

(3045414) Leukocytes [Presence] in Urine

1805

12861

1.34

28.94

1.9

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2934

22301

1.26

28.72

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

928

5900

1.49

28.69

1.5

107.96

112.16

u/ml

0.69

233

1304

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

991

6399

1.47

28.35

1.2

1.3

—

(4062490) Immunoglobulin typing, IgG

535

3007

1.68

28.06

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

534

3003

1.68

27.95

1.4

2.83

2.98

g/l

1.18

376

2119

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2224

16392

1.29

27.93

2.7

3.2

37.51

48.80

u/ml

2.19

2129

15856

(3027135) IgG subclass 1 [Mass/volume] in Serum

534

3007

1.68

27.82

1.4

6.31

6.82

g/l

2.94

372

2123

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

994

6447

1.46

27.80

1.2

1.3

4.02

3.67

mmol/l

14.19

913

6070

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1171

7830

1.42

27.79

1.3

4.69

9.46

u/ml

4.09

159

1240

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

327

1589

1.95

27.78

1.4

1.5

20.33

24.27

u/ml

0.86

295

(3024139) IgG subclass 3 [Mass/volume] in Serum

533

3003

1.68

27.71

1.4

0.40

g/l

0.09

375

2126

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1257

8520

1.40

27.60

1.3

28.66

36.88

u/ml

0.42

527

(3008757) Leukocyte morphology finding [Identifier] in Blood

490

2704

1.72

27.51

2.9

3.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

278

1281

2.05

27.44

2.2

22.33

31.61

umol/l

0.64

120

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

233

1003

2.19

27.43

1.3

1.4

13.26

14.78

pmol/l

4.10

194

848

(3027944) Amphetamines [Presence] in Urine

1945

14116

1.31

27.39

2.0

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

937

6030

1.47

27.28

1.3

272.89

264.09

u/ml

0.43

577

3955

(3008116) Ketones [Moles/volume] in Urine by Test strip

146

509

2.71

27.24

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2264

16816

1.28

26.75

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

439

2368

1.75

26.75

1.5

2.2

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

357

1810

1.86

26.69

2.5

2.1

98.53

98.86

0.07

328

1675

(43055514) Macroprolactin [Presence] in Serum or Plasma

217

923

2.22

26.33

1.5

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

355

1805

1.86

26.31

1.6

1.3

5.65

5.50

mmol/l

1.52

336

1713

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1579

11189

1.34

26.27

1.9

1.8

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

364

1872

1.84

26.03

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

497

2804

1.68

25.74

1.7

1.6

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

194

795

2.30

25.74

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

568

3320

1.62

25.61

1.8

1.5

8.44

7.50

mmol/l

18.39

530

3204

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1142

7716

1.41

25.56

1.3

6.14

6.60

u/ml

0.08

111

805

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

959

6280

1.45

25.53

1.2

1.3

4.36

5.35

u/ml

0.21

479

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

947

6189

1.45

25.48

1.2

11.79

14.99

u/ml

0.15

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

316

1565

1.91

25.42

1.3

1.2

83.84

87.56

u/l

0.33

280

1363

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

439

2407

1.73

25.28

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1092

7357

1.41

24.86

1.3

1.4

522.02

514.39

mg/l

0.09

1027

7028

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1135

7703

1.40

24.76

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

421

2296

1.73

24.72

3.1

2.8

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

308

1529

1.90

24.62

1.3

1.2

21.59

22.58

u/l

0.17

265

1314

(3017315) Amylase [Enzymatic activity/volume] in Urine

299

1473

1.92

24.47

1.4

1.2

291.19

319.41

u/l

0.21

280

1374

(3004616) Nuclear Ab [Presence] in Serum

594

3553

1.58

24.35

1.3

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

506

2916

1.64

24.18

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

505

2917

1.64

23.92

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1131

7722

1.39

23.82

1.9

11.03

20.98

iu/l

0.45

414

2945

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2761

31448

0.81

23.11

1.7

—

(1761868) Lipid panel - Serum or Plasma

12726

110835

1.12

22.99

3.3

2.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

423

2365

1.69

22.74

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

175

3.77

22.69

1.6

1.8

44.94

45.76

umol/l

0.08

175

(3006922) Hepatitis E virus Ab [Presence] in Serum

381

2073

1.74

22.61

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

476

2765

1.63

22.09

1.5

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

441

2515

1.66

22.01

1.5

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

418

2355

1.68

21.86

1.7

1.5

1.28

1.43

promille

1.36

321

1805

(3032057) Clostridioides difficile [Presence] in Stool

131

485

2.55

21.79

1.9

1.8

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

220

1016

2.04

21.72

1.9

2.5

0.77

1.21

ug/l

3.46

201

970

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

389

2156

1.71

21.63

1.4

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1803

21355

0.78

21.41

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1490

10784

1.31

21.40

1.7

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

144

565

2.40

21.18

1.5

1.4

13.01

13.39

g/l

0.20

117

416

(3049717) Cytology report of Urine Cyto stain

1225

8634

1.35

21.15

2.2

2.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

315

1655

1.80

21.12

1.4

1.5

6.85

8.08

ug/l

1.11

284

1492

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

172

730

2.22

21.11

2.3

1.8

7294.93

11640.85

e6/l

0.60

386

(3035947) Staphylolysin Ab [Units/volume] in Serum

263

1312

1.89

20.81

1.2

1.1

3.45

3.65

iu/ml

0.17

(3044290) Cell count panel - Cerebral spinal fluid

906

6104

1.41

20.68

1.3

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

284

1456

1.84

20.64

1.1

8.76

10.07

u/ml

0.20

262

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

547

3338

1.55

20.63

1.2

1.1

97.21

94.62

1.36

512

3126

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

869

5816

1.42

20.61

5.4

6.0

6302.45

1234.72

iu/ml

0.43

112

868

(3034891) Synovial lining cells/100 cells in Synovial fluid

251

1241

1.91

20.42

1.5

4.63

3.77

0.39

285

(3042631) Mycobacterium sp identified in Specimen

522

3161

1.56

20.38

2.4

2.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1065

7389

1.37

20.37

1.4

123.79

118.64

pmol/l

0.16

1026

7215

(3039443) Prostate specific Ag panel - Serum or Plasma

300

4900

0.57

20.37

1.6

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

555

3410

1.54

20.31

1.2

1.1

0.99

2.22

iu/ml

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

187

837

2.11

20.11

2.3

1.9

7357.03

2346.90

e6/l

0.50

127

569

(3013166) Neutrophils/100 leukocytes in Synovial fluid

171

739

2.18

20.10

1.6

1.4

53.96

52.41

0.20

148

635

(3003181) Sodium [Moles/volume] in Urine

629

3978

1.50

20.09

1.4

63.69

64.00

mmol/l

0.06

467

3151

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

330

1795

1.74

19.68

1.5

1.9

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

361

2013

1.69

19.68

1.1

1.07

1.06

ratio

0.17

119

735

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

261

3.03

19.47

8.6

7.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

201

937

2.02

19.40

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

176

781

2.13

19.37

3.0

3.4

55.89

52.08

1.59

170

761

(3033799) Differential panel - Peritoneal fluid

167

727

2.17

19.30

2.3

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

129

504

2.41

19.21

1.3

1.6

—

(40762365) Oxygen content in Arterial blood by calculation

106

377

2.65

19.18

2.7

3.0

14.86

14.84

ml/dl

0.02

352

(3002331) Protein [Mass/volume] in Peritoneal fluid

127

496

2.41

18.93

1.5

1.4

25.94

28.66

g/l

0.39

380

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

320

1746

1.73

18.90

1.3

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

272

1416

1.81

18.87

1.2

1.3

601.05

410.38

titre

0.28

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

310

1679

1.74

18.80

1.6

6.18

7.17

u/l

0.71

244

1345

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

342

1904

1.70

18.78

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

162

705

2.17

18.76

3.6

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

162

705

2.17

18.76

3.6

2.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

343

1913

1.69

18.72

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

100

350

2.69

18.69

6.2

5.4

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

266

1380

1.82

18.67

1.2

1.3

75.79

74.61

titre

0.02

115

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1253

9036

1.32

18.50

1.1

4.29

5.44

u/ml

0.63

147

1300

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

5.98

18.49

4.8

5.7

0.25

0.24

mmol/l

0.08

(3035320) C reactive protein [Mass/volume] in Body fluid

359

2034

1.67

18.47

3.1

2.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

250

3.02

18.39

1.5

109.91

114.40

ug/l

0.12

210

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

120

463

2.44

18.38

3.5

2.1

7.75

7.44

mmol/l

0.31

277

(3017354) Segmented neutrophils/100 leukocytes in Blood

422

2504

1.59

18.05

2.8

3.3

58.72

56.34

1.66

355

2137

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

371

2133

1.64

18.04

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

215

1055

1.92

17.97

1.0

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

675

4427

1.44

17.96

2.6

3.0

513.18

7138.68

u/ml

1.42

252

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1248

9036

1.31

17.91

1.4

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

319

1771

1.70

17.74

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

158

697

2.14

17.71

1.5

1.2

79.81

136.02

nmol/l

6.27

113

528

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

937

6522

1.36

17.61

1.4

1.5

1072.93

2338.88

e6/l

1.00

752

5286

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

935

6517

1.36

17.43

1.3

1.4

58.54

23.10

e6/l

1.00

713

5022

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2626

20769

1.20

17.35

2.4

2.3

23.32

22.65

au/ml

0.11

138

1795

(3026389) Candida sp identified in Specimen by Organism specific culture

672

4440

1.43

17.20

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2419

19028

1.21

16.92

1.3

42.77

50.06

au/ml

0.64

961

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

359

2.57

16.78

14.5

9.5

5.52

5.28

mmol/l

0.35

359

(3038026) Centromere Ab [Units/volume] in Serum

386

2287

1.59

16.66

1.2

41.66

48.86

u/ml

—

108

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

271

1468

1.74

16.50

1.6

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

179

850

1.99

16.50

6.9

6.2

25.67

24.90

mmol/l

1.28

162

779

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

259

1390

1.76

16.30

1.1

21.77

24.08

u/l

0.34

238

1258

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

351

2053

1.61

16.00

1.3

1.2

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

258

1391

1.75

15.99

1.1

80.71

83.52

u/l

0.30

238

1259

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

353

2068

1.61

15.99

1.3

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

247

1320

1.77

15.79

1.9

2.3

22.03

166.05

ug/l

1.82

235

1259

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1562

11827

1.25

15.72

1.4

1.3

197.81

227.38

miu/ml

2.66

649

5741

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

919

6493

1.34

15.71

1.2

34.00

43.54

u/ml

0.95

640

(3036180) Methadone [Presence] in Urine

283

1574

1.70

15.70

2.2

2.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

512

3274

1.48

15.61

2.4

2.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

205

1042

1.86

15.46

1.2

110.46

111.04

0.13

177

939

(44813793) Dust mix specific IgE antibody measurement

379

2281

1.57

15.35

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

168

3.25

15.20

2.0

1.3

350.84

323.96

umol/24h

0.40

168

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

373

2242

1.57

15.19

1.2

1.3

0.93

1.86

u/ml

1.95

200

1229

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

372

2235

1.57

15.18

1.2

82.56

66.07

u/ml

0.42

106

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

217

1130

1.81

15.16

1.2

0.32

0.30

g/l

2.49

172

893

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1139

8338

1.29

15.11

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

372

2241

1.57

15.01

1.2

50.72

43.43

u/ml

0.22

168

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

289

1638

1.67

14.96

1.1

2.03

6.06

nmol/l

1.84

311

(3022493) Free Hemoglobin [Mass/volume] in Plasma

213

1112

1.81

14.77

5.9

5.0

1836.44

2989.46

mg/l

0.38

152

820

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

390

2387

1.54

14.68

1.9

1.7

—

(3024263) Appearance of Synovial fluid

241

1310

1.74

14.57

1.5

1.4

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

356

2148

1.57

14.30

1.2

6.00

10.76

u/ml

0.71

162

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

419

2621

1.51

14.28

1.3

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

189

965

1.85

14.11

2.5

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

750

5227

1.36

14.08

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

270

1531

1.66

14.00

1.7

2.0

150.13

135.70

2.10

254

1446

(3051611) Lipemic interference index of Serum or Plasma

431

2725

1.49

13.96

3.5

3.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

291

1684

1.63

13.93

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

652

4455

1.38

13.86

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

215

1149

1.77

13.82

3.1

3.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

238

1312

1.71

13.72

1.6

1.5

—

(3008295) Osmolality of Serum or Plasma

401

2509

1.51

13.67

1.5

283.29

279.98

mosm/kgh2o

1.99

304

1978

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

238

1314

1.71

13.65

1.5

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

332

1996

1.57

13.58

2.1

1.9

2.30

2.09

u/field

0.30

152

926

(3051651) Icteric interference index of Serum or Plasma

276

1587

1.64

13.57

3.9

3.7

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

264

1507

1.65

13.36

1.1

—

(3027035) Albumin [Mass/time] in 24 hour Urine

219

2.80

13.19

1.3

669.01

235.48

mg/24h

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

236

1318

1.69

13.00

1.5

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

254

1448

1.66

12.94

1.1

99.72

96.17

1.02

189

1163

(3042733) HLA Ab [Presence] in Serum

193

1020

1.79

12.92

5.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

196

1043

1.77

12.83

3.5

4.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

506

3356

1.42

12.82

1.5

1.6

30.58

34.14

iu/ml

0.26

167

(3051593) INR in Capillary blood by Coagulation assay

186

975

1.80

12.81

12.9

8.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

948

6930

1.30

12.78

1.1

1.52

2.16

u/ml

1.93

527

3423

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

668

4648

1.36

12.72

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

267

1551

1.62

12.64

1.2

25.82

10.36

u/ml

0.29

169

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

817

5865

1.32

12.60

1.5

1.4

0.39

0.43

nmol/l

0.56

657

4625

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

236

1330

1.67

12.58

1.6

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

4224

35519

1.13

12.56

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3373

27950

1.15

12.49

2.0

1.9

—

(3044007) Cell count panel - Peritoneal fluid

139

672

1.95

12.32

2.4

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

200

1087

1.74

12.19

1.1

93.86

91.29

0.60

494

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

201

1096

1.73

12.12

3.0

2.8

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

106

467

2.14

12.10

2.2

2.7

95.06

37.49

mg/l

1.09

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

115

524

2.07

12.03

2.9

2.4

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

117

540

2.04

11.83

1.2

14.87

57.73

mg/l

1.13

398

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

358

2259

1.50

11.80

3.4

3.8

—

(40768800) Prostate Pathology biopsy report

318

4491

0.66

11.78

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

853

6224

1.30

11.71

1.1

4.17

5.54

u/ml

2.40

457

3172

(3008401) Mugwort IgE Ab [Units/volume] in Serum

813

5911

1.30

11.47

1.1

1.01

1.13

u/ml

0.16

359

2479

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

262

1555

1.59

11.42

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

226

2.63

11.40

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

296

1810

1.54

11.33

2.8

3.3

113.84

126.55

nmol/l

0.31

290

1774

(3039162) Centromere protein B Ab [Units/volume] in Serum

561

3871

1.37

11.33

1.3

1.2

35.80

53.64

u/ml

1.00

263

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

412

2.17

11.31

4.0

4.8

63.75

40.90

ug/min

1.72

312

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

356

2265

1.48

11.29

1.1

1.3

2.11

2.01

mmol/l

0.62

322

2116

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

245

2.54

11.16

2.0

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

268

2.46

11.10

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5725

58739

0.90

11.03

3.9

4.0

22.46

21.74

2.40

2285

27273

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

418

2.14

10.93

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

475

3209

1.40

10.92

1.3

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

417

2755

1.43

10.89

1.5

1.4

33.35

33.75

g/l

0.27

386

2493

(40768446) Kidney Pathology biopsy report

203

1146

1.67

10.84

1.6

1.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

198

1111

1.68

10.82

1.1

1.2

115.15

109.53

1.18

178

1004

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

402

2.16

10.78

1.1

—

(3016038) Potassium [Moles/volume] in Urine

255

1533

1.57

10.56

1.2

1.3

31.39

34.60

mmol/l

1.46

211

1331

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

190

1065

1.68

10.44

1.1

97.36

92.47

0.94

489

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

445

2.08

10.41

5.7

6.0

65.66

70.17

0.88

350

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2670

22055

1.15

10.32

1.8

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.61

10.26

2.1

2.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

314

2.28

10.22

2.8

2.5

1.40

1.23

mmol/l

0.19

220

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

785

1.79

10.20

1.6

10.64

8.77

ug/l

4.21

149

785

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

273

1682

1.53

10.16

1.6

1.4

6.04

5.88

u/l

0.10

237

1409

(3014051) Protein [Presence] in Urine by Test strip

965

7283

1.25

10.13

2.6

2.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

196

1121

1.65

10.00

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

139

722

1.82

9.99

1.7

1.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

243

1466

1.56

9.95

1.3

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

397

2.11

9.93

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1552

12327

1.19

9.84

1.4

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

142

2.92

9.76

2.0

1.7

0.59

0.71

0.21

107

(4094501) Cardiovascular stress test using bicycle ergometer

967

7337

1.25

9.70

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

112

550

1.92

9.60

1.1

0.89

0.76

umol/24h

0.22

281

(3010375) cycloSPORINE [Mass/volume] in Blood

218

1298

1.58

9.47

28.3

28.4

117.24

119.37

ug/l

0.16

174

1086

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

429

2931

1.38

9.31

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

259

1611

1.52

9.27

1.5

1.4

13.16

12.25

u/l

1.15

254

1561

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

315

2039

1.46

9.26

1.1

6.67

8.51

iu/ml

1.22

531

(3018133) Calcium [Moles/volume] in Urine

454

1.99

9.19

2.1

3.04

2.55

mmol/l

1.12

409

(3024932) HLA-DR beta [Type]

175

995

1.66

9.18

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

196

2.55

9.11

2.4

2.3

66.90

57.12

1.07

119

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

182

1048

1.64

9.09

1.6

2.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

171

969

1.66

9.09

1.1

2.46

16.79

u/ml

0.78

558

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

639

4651

1.30

9.05

1.1

—

(3001729) Color of Synovial fluid

175

2.64

9.03

1.9

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

117

598

1.84

8.91

1.4

1.6

0.43

0.38

ug/l

0.68

400

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

179

1032

1.64

8.91

1.5

2.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

372

2506

1.40

8.81

1.5

5509.83

3226.29

e6/l

0.41

276

1803

(3024471) HLA-A [Type]

177

1022

1.63

8.76

1.0

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

456

1.96

8.75

1.1

1.0

0.29

0.34

u/ml

0.08

274

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

178

1032

1.63

8.68

1.5

2.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

318

2091

1.44

8.64

1.3

1.4

12.74

11.60

umol/l

1.94

283

2002

(3006462) Nitrate [Presence] in Urine

221

1351

1.54

8.61

3.4

2.8

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

260

2.28

8.56

1.0

1.2

39.01

45.90

mg/l

1.74

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

154

2.69

8.46

2.3

13.43

17.11

0.44

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

288

1874

1.45

8.30

1.3

587.15

496.85

u/l

0.22

274

1777

(3017704) Immunofixation for Urine

203

1236

1.55

8.08

1.3

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

217

1341

1.53

8.08

36.9

36.0

7.28

7.37

ug/l

0.28

196

1218

(3028433) Virus identified in Specimen by Culture

162

936

1.63

8.05

1.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4161

42740

0.91

8.00

2.8

2.9

0.67

0.74

ug/l

3.82

2752

27140

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

305

2.13

7.97

2.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

431

3025

1.35

7.96

3.0

3.2

5.84

7.64

nmol/l

0.43

398

2939

(3023410) Appearance of Cerebral spinal fluid

430

3017

1.35

7.96

1.4

1.6

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

394

1.98

7.93

1.3

1.5

443755.28

187995.51

nmol/l

0.46

333

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

612

4547

1.27

7.47

1.1

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

113

606

1.76

7.43

1.3

3.61

3.54

mmol/l

0.08

105

556

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

304

2041

1.41

7.43

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

128

712

1.69

7.39

1.3

37.33

40.18

g/l

1.33

376

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

359

2495

1.36

7.13

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

369

2576

1.35

7.12

1.1

232.60

259.25

mg/l

1.74

317

2268

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

380

2665

1.35

7.12

1.1

1.2

42.95

41.83

mg/l

0.15

322

2223

(3002619) Bacteria identified in Specimen by Culture

105

559

1.77

7.10

1.3

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

185

1138

1.53

7.10

1.8

2.0

171.22

156.15

1.07

174

1073

(3028308) Erythrocytes [#/volume] in Pleural fluid

332

2285

1.37

7.02

1.5

79232.64

49054.41

e6/l

0.93

193

1361

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

159

2.49

6.97

1.1

—

(3035880) pH of Pleural fluid

180

1107

1.53

6.93

1.2

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

334

2308

1.37

6.90

1.8

2.1

74.34

73.19

0.79

327

2214

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

527

3892

1.28

6.80

2.4

2.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

117

651

1.69

6.79

1.3

36.93

40.02

0.35

447

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

214

2.24

6.76

1.4

1.3

0.99

1.68

ml/s/173m2

0.94

144

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

102

2.86

6.74

1.1

1.4

584.16

483.48

nmol/l

0.42

102

(3047189) Immunofixation for 24 hour Urine

172

1055

1.54

6.72

1.5

1.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

116

647

1.69

6.68

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

622

4696

1.25

6.68

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

227

1477

1.45

6.65

1.7

2.42

2.38

u/field

0.02

162

1066

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

529

1.76

6.64

1.3

1.5

0.20

0.26

nmol/l

1.08

387

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

135

2.58

6.64

1.0

0.29

0.08

u/ml

0.69

(3047352) Trisomy 18 risk [Likelihood] in Fetus

881

9916

0.83

6.58

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.18

6.50

1.1

1.2

—

(40768793) Breast Pathology biopsy report

591

6913

0.80

6.49

1.3

—

(37019676) Renin [Units/volume] in Plasma --supine

3.69

6.49

1.0

1.1

81.15

64.17

mu/l

0.15

(4281824) Cell count and differential, peritoneal fluid

424

3070

1.30

6.40

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

168

1037

1.53

6.40

1.1

1.0

7.20

11.25

u/ml

1.85

605

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

179

1121

1.51

6.37

2.3

2.7

156.20

152.10

au/ml

0.04

164

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

778

6050

1.21

6.34

1.7

—

(3011412) CD3 cells [#/volume] in Blood

403

2903

1.31

6.33

2.1

2.5

1.35

1.19

e9/l

3.23

364

2583

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

408

1.85

6.28

1.1

—

(3013466) aPTT in Blood by Coagulation assay

197

2.25

6.27

1.1

39.27

36.04

1.15

163

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

485

1.77

6.19

1.4

24.99

24.01

0.11

404

(3043238) Trisomy 21 risk [Likelihood] in Fetus

908

10132

0.84

6.18

1.6

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

112

633

1.67

6.18

7.5

8.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

271

1847

1.38

6.15

1.9

1.7

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

185

1176

1.48

6.15

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.14

6.12

1.3

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

757

5894

1.21

6.11

1.1

1.64

2.00

u/ml

0.59

415

2871

(3005033) Fetal Nuchal fold Thickness US

886

9892

0.84

6.08

1.5

1.4

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

502

1.75

6.07

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1109

8948

1.17

6.00

3.0

3.6

1115.72

2037.74

u/ml

0.47

928

7696

(3042517) Benzodiazepines panel - Urine

401

1.83

5.99

2.7

2.9

—

(3041806) Other cells [#/volume] in Blood by Manual count

107

1637

0.61

5.99

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

301

2098

1.35

5.96

1.5

1.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

228

2.11

5.84

1.2

1.4

67.35

69.57

0.17

187

(40762814) Titanium [Mass/volume] in Blood

371

1.85

5.83

2.3

2.4

3.75

3.92

ug/l

0.09

132

(21491868) Cryoglobulin [Mass/volume] in Serum

159

992

1.51

5.81

1.2

0.14

0.58

g/l

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

393

4748

0.78

5.75

3.1

3.6

26.20

37.23

u/ml

1.54

374

4586

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

418

3069

1.29

5.73

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

354

1.86

5.68

2.4

2.6

77.92

66.10

pmol/l

0.27

303

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

158

2.32

5.66

1.2

146.65

105.53

ug/l

0.97

101

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

189

1228

1.45

5.66

2.8

3.2

7.58

8.17

mg/l

0.54

149

977

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

122

722

1.59

5.65

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

403

1.80

5.61

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.76

5.56

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

116

682

1.60

5.53

1.5

2.0

31.65

37.76

u/l

0.17

103

608

(3005082) Progesterone [Moles/volume] in Serum or Plasma

327

2336

1.32

5.52

1.5

1.3

24.24

32.64

nmol/l

8.14

287

2160

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

166

1058

1.48

5.50

2.7

2.4

146.64

153.37

nmol/l

0.40

149

926

(3038177) Helicobacter pylori Ab [Presence] in Serum

680

5301

1.21

5.47

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

482

3624

1.26

5.46

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

210

2.11

5.42

1.4

7.17

14.21

pmol/l

1.52

172

(3026470) Cobalt [Mass/volume] in Blood

203

1351

1.42

5.36

2.1

2.0

5.04

3.12

ug/l

1.29

180

1244

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

170

1096

1.46

5.33

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

174

1127

1.46

5.32

2.0

6.98

9.59

mg/l

9.48

142

906

(3036782) Glucose [Moles/volume] in Pleural fluid

288

2033

1.34

5.30

1.3

6.75

6.26

mmol/l

2.11

265

1876

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

218

1474

1.39

5.27

1.3

14.69

14.45

u/l

0.04

201

1362

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

302

2150

1.32

5.25

1.9

2.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

587

4531

1.22

5.24

1.8

2.0

7.75

7.76

titre

0.00

105

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

226

2.04

5.21

1.2

16.62

15.94

nmol/l

0.09

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

390

2877

1.28

5.20

3.9

4.7

127.35

110.26

u/ml

0.18

117

935

(3001686) Cold agglutinin [Titer] in Serum or Plasma

456

1.71

5.16

1.2

1.4

25.00

167.79

titre

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

103

600

1.62

5.13

1.1

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

234

2.01

5.12

1.4

1.2

22.66

20.94

mmol/l

1.42

187

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.74

5.08

1.0

1.1

175.14

234.20

pmol/l

0.50

(3012441) Differential panel - Pleural fluid

302

2165

1.32

5.02

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

298

2134

1.32

4.99

2.2

2.6

550.31

514.79

e6/l

0.69

255

1779

(40757373) Influenza virus identified in Isolate

489

1.68

4.99

1.8

1.6

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

180

1189

1.43

4.99

2.5

2.4

52.24

51.30

umol/l

0.13

150

1036

(3025577) Chromium [Mass/volume] in Blood

197

1323

1.40

4.98

2.1

2.74

2.22

ug/l

0.51

157

1114

(3011436) Histone Ab [Units/volume] in Serum

103

605

1.60

4.98

1.1

—

28.45

u/ml

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

341

2491

1.29

4.94

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2981

25856

1.09

4.93

3.4

4.1

22.33

23.89

ug/l

0.11

2361

20403

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

366

1.78

4.87

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

346

1.80

4.84

8.2

6.6

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

122

2.39

4.84

1.0

0.14

0.06

u/ml

0.36

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

552

1.62

4.81

1.3

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

145

931

1.47

4.70

1.3

1.2

—

(3045788) Cell count panel - Pleural fluid

272

1943

1.32

4.67

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1161

12426

0.88

4.67

1.5

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

111

675

1.55

4.66

1.0

1.1

1.91

3.54

u/ml

0.44

568

(3010370) Gastrin [Moles/volume] in Serum or Plasma

435

1.69

4.64

1.8

1.7

44.23

56.36

pmol/l

0.43

371

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

729

1.53

4.61

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

172

1145

1.42

4.61

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

637

5026

1.20

4.59

1.1

16.44

10.65

au/ml

0.54

346

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

288

2080

1.31

4.58

2.2

2.6

0.23

e9/l

0.18

254

1784

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

150

2.20

4.53

1.1

1.3

—

303.33

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.90

4.52

1.0

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

585

1.58

4.47

1.3

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

563

1.59

4.47

7.6

8.9

—

(3051339) Copper [Moles/volume] in Blood

151

2.18

4.46

1.3

17.38

16.49

umol/l

0.48

132

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

386

2903

1.25

4.46

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

229

1608

1.34

4.45

1.2

1.3

—

(3029612) Listeria sp Ab [Titer] in Serum

2.78

4.44

1.2

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

363

1.74

4.44

1.8

3.4

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

189

2.04

4.42

1.0

1.2

37.00

19.08

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

115

714

1.52

4.41

1.2

120.91

106.25

3.72

110

670

(3016228) CD19 cells/100 cells in Blood

169

1132

1.41

4.39

1.8

2.1

8.83

8.50

0.14

164

1106

(3000919) Neutrophils/100 leukocytes in Pleural fluid

545

1.59

4.35

1.3

1.4

26.08

22.03

0.65

500

(3045683) HLA typing for celiac disease panel - Blood or Tissue

280

2033

1.30

4.31

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

253

1813

1.32

4.29

1.1

1.17

1.05

u/l

0.36

107

808

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

111

689

1.52

4.28

1.2

90.32

88.43

0.14

178

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

111

689

1.52

4.28

1.2

69.25

77.82

0.75

171

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

204

1417

1.36

4.27

1.2

1.3

—

(44786800) Granulocytes/100 leukocytes in Body fluid

244

1.89

4.27

1.2

1.3

26.62

26.27

0.02

189

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

198

1369

1.36

4.27

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.77

4.19

10.2

8.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

363

1.71

4.17

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

109

679

1.51

4.15

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.67

4.13

1.1

—

mmol/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

116

734

1.49

4.10

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.73

4.09

1.9

1.5

153.00

322.82

nmol/l

1.41

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

629

1.53

4.07

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

164

1110

1.39

4.05

1.8

2.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

149

993

1.41

4.03

2.4

3.0

30.08

28.38

umol/l

0.85

103

770

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.96

4.02

1.9

2.2

2.37

2.23

mu/l

0.05

(3042111) Morphology [Interpretation] in Bone marrow Narrative

500

3912

1.21

4.01

1.7

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

629

5031

1.18

3.94

2.8

3.4

631.95

837.78

u/ml

0.32

567

4572

(3020393) Adenovirus Ag [Presence] in Stool

306

1.75

3.94

1.2

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

391

1.66

3.93

1.2

1.59

1.79

mmol/l

0.53

230

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

218

1551

1.32

3.93

1.1

1544.84

1494.11

miu/ml

0.27

218

1551

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

138

912

1.43

3.92

1.8

1.7

180.26

123.15

au/ml

0.67

107

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

113

719

1.48

3.91

1.1

—

(40768806) Pleura Pathology biopsy report

293

2171

1.27

3.89

1.6

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

596

4752

1.18

3.89

1.1

5.76

5.02

u/ml

0.25

257

1936

(3001218) Citrate [Mass/time] in 24 hour Urine

4.08

3.87

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

114

730

1.47

3.83

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

194

1.94

3.80

1.1

1.30

1.53

u/ml

0.09

137

(3010503) CD19 cells [#/volume] in Blood

239

1738

1.30

3.70

2.3

2.6

0.19

0.32

e9/l

1.05

230

1697

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

113

728

1.46

3.70

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

607

1.51

3.66

1.2

1.4

2.36

2.75

0.16

516

(1617658) Protocol used for examination of sentinel lymph nodes

176

2212

0.75

3.63

1.0

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

112

724

1.46

3.61

1.3

1.4

59.02

61.35

0.29

602

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

186

1311

1.34

3.61

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

365

1.65

3.59

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

460

1.58

3.59

1.2

1.4

60.13

295.04

ng/l

0.66

284

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

179

1256

1.34

3.58

1.1

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

475

1.57

3.58

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

260

1.77

3.56

1.0

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

167

1.97

3.51

1.2

1.8

201.77

172.80

ug/g

0.49

145

(3048879) Bone marrow aspiration report

103

660

1.47

3.49

1.3

2.0

—

(3003157) Bacteria [#/volume] in Mother's milk

2.56

3.47

5.3

7.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

201

1.87

3.46

1.0

0.08

0.60

u/ml

1.90

184

(3011325) HIV 1+2 Ab [Presence] in Serum

149

2.02

3.43

1.1

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

378

1.62

3.40

1.3

55.93

53.19

0.16

185

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

357

1.64

3.38

1.0

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

302

1.68

3.29

1.2

—

(3019174) dRVVT (LA screen)

288

1.70

3.28

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

322

2466

1.23

3.28

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

623

5065

1.16

3.26

1.1

4.83

4.31

u/ml

0.21

315

2359

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

322

2469

1.23

3.25

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

205

1491

1.30

3.23

1.3

61.39

66.33

0.29

177

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

541

1.50

3.22

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

297

1.68

3.22

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

153

1.97

3.22

2.5

2.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

321

2464

1.23

3.21

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

151

1053

1.35

3.20

1.0

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.38

3.19

1.7

1.5

266.67

247.67

nmol/l

0.05

(3027874) Urate [Moles/volume] in Urine

2.38

3.19

1.1

1.14

1.80

mmol/l

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

324

2493

1.23

3.17

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

323

2488

1.22

3.13

1.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.42

3.12

1.0

1.1

1543.60

3960.69

ng/l

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

323

2490

1.22

3.11

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

216

1.79

3.09

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

840

7003

1.13

3.08

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

111

741

1.41

3.07

1.3

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.19

3.04

1.2

1.5

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.60

3.03

1.3

1.0

1.31

1.33

u/field

0.02

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

118

2.07

3.02

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

136

943

1.36

3.01

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.50

3.00

11.6

7.8

48.64

44.65

0.19

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

368

2887

1.20

2.98

1.8

2.0

24.92

24.55

ug/l

0.03

357

2825

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

304

1.64

2.97

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.35

2.96

1.0

1.1

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.20

2.96

1.1

0.88

1.40

u/field

0.84

(3019897) Erythrocyte distribution width [Ratio] by Automated count

456

5034

0.85

2.96

3.4

2.4

13.49

13.12

9.37

450

4971

(3006245) CD3-CD19+ cells/100 cells in Blood

172

1239

1.31

2.95

2.0

2.3

10.66

10.30

0.15

166

1149

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

152

1.92

2.93

1.0

1.2

1.18

1.22

u/field

0.07

102

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

675

5571

1.14

2.91

1.6

1.5

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

321

1.61

2.89

3.6

3.4

39.31

42.31

umol/l

0.47

277

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

250

1.70

2.86

1.3

1.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

404

1.54

2.85

1.1

1.3

32.42

42.66

mg/l

1.64

349

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

137

961

1.34

2.84

2.1

1.7

3570.56

31503.21

u/ml

1.17

117

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

542

1.46

2.82

1.1

—

(3034426) Prothrombin time (PT)

153

1092

1.32

2.82

1.3

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

506

4101

1.16

2.82

1.1

1.0

0.67

0.34

u/ml

0.50

168

1032

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

244

1.70

2.82

1.0

1.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

280

1.65

2.81

1.6

0.63

1.99

mg/l

4.04

184

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

551

1.45

2.79

1.4

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

413

3296

1.18

2.79

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

224

1.72

2.77

1.0

1.1

—

2.64

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

184

1352

1.28

2.75

1.2

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.64

2.74

1.1

1.0

0.02

0.09

g/l

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

156

1.87

2.73

1.1

37.42

61.78

u/l

1.51

123

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

127

1595

0.75

2.72

1.3

—

(3042301) Urate [Moles/volume] in Synovial fluid

2.72

2.70

1.0

502.33

361.29

umol/l

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

306

1.60

2.67

1.2

1.3

0.73

1.33

mmol/l

0.94

192

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

713

5950

1.13

2.63

1.3

3.53

3.60

ug/l

0.11

652

5381

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

878

1.34

2.60

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

119

1.98

2.59

1.2

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

490

1.46

2.59

2.6

4.9

51.76

67.36

u/l

0.71

481

(3001964) Herpes simplex virus Ag [Presence] in Specimen

128

904

1.33

2.57

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

106

727

1.37

2.57

1.2

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

160

1.82

2.55

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.05

2.53

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

2.60

2.50

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

274

2132

1.21

2.49

1.2

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

592

4905

1.14

2.47

1.1

3.31

2.84

u/ml

0.33

254

2476

(3000219) Insulin receptor Ab [Presence] in Serum

6.72

2.44

1.0

—

(3009015) Lactate [Moles/volume] in Synovial fluid

255

1.62

2.43

1.4

1.2

5.69

6.24

mmol/l

0.24

123

(3037692) Legionella sp identified in Specimen by Organism specific culture

130

929

1.32

2.43

1.6

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

285

1.59

2.41

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

383

1.50

2.40

1.0

—

(36303858) Crystals [Presence] in Urine

2.88

2.37

1.1

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

257

1.61

2.37

1.3

80.55

329.97

u/l

0.76

187

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

468

3832

1.15

2.34

1.6

1.7

4912.00

3256.47

titre

—

136

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

186

1.72

2.33

1.1

8.85

9.79

u/l

0.14

186

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

348

1.52

2.32

1.8

1.7

2.00

1.58

mg/l

1.02

290

(3024869) Neuronal Ab [Presence] in Serum

464

1.44

2.30

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

180

1.73

2.29

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

188

1421

1.25

2.29

1.5

1.6

2175934.36

1740942.73

iu/ml

0.15

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

161

1195

1.27

2.28

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

161

1195

1.27

2.28

1.5

1.6

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

1.80

1.73

mg/l

0.05

198

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

0.32

0.98

mg/l

2.57

186

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

2.36

2.09

mg/l

0.11

204

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

0.99

2.38

mg/l

2.56

181

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

1.82

2.73

mg/l

0.47

193

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

3.12

3.97

mg/l

0.42

176

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

0.71

2.11

mg/l

3.18

166

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

2.09

2.58

mg/l

0.30

190

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

275

1.58

2.27

1.6

0.75

1.29

mg/l

0.87

175

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

242

1882

1.21

2.25

1.5

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.35

2.22

1.1

0.05

0.21

g/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

375

1.48

2.21

1.4

1.6

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

120

1.88

2.21

1.5

0.00

0.03

u/l

0.49

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

370

1.48

2.15

1.0

0.03

0.20

u/ml

2.44

221

(3013247) Albumin in CSF/Albumin in Serum or Plasma

105

743

1.33

2.15

1.0

1.1

6.09

6.60

mg/g

0.60

100

704

(3001019) Free T4 and TSH panel - Serum or Plasma

2157

19128

1.07

2.14

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

559

1.38

2.13

1.3

282.25

318.72

ug/l

0.05

299

(3050794) Legionella sp Ab [Presence] in Serum

228

1.61

2.12

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

178

1.69

2.10

2.8

5.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

116

1415

0.77

2.10

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

267

1.55

2.06

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

298

1.52

2.04

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

125

915

1.29

2.02

2.8

3.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

422

1.43

2.02

6.2

7.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

120

874

1.29

2.02

1.8

2.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

3.47

2.02

1.0

1.1

—

(4212803) Bone marrow aspirate examination

195

1.64

2.01

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.23

2.00

1.0

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.97

1.99

1.1

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

132

1.78

1.97

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

441

1.41

1.95

1.6

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

175

1.67

1.95

1.3

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

228

1.57

1.89

1.3

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

141

1.74

1.89

3.6

3.3

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.92

1.89

1.1

1.2

265.52

262.38

nmol/l

0.02

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.65

1.85

1.3

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

153

1163

1.24

1.84

1.1

358.56

614.44

ng/l

0.52

271

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

208

1.58

1.82

1.3

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.98

1.82

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.93

1.80

1.0

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.26

1.77

1.0

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

474

1.37

1.77

1.6

1.3

—

(40758358) Immune stain study

123

1.76

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

240

1.53

1.76

1.0

1.65

0.89

u/ml

0.18

154

(21494434) Karyotype in Bone marrow

256

2058

1.17

1.73

1.1

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.22

1.70

1.0

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

232

1859

1.18

1.65

2.0

1.6

—

(3020874) Milk IgE Ab [Units/volume] in Serum

269

2183

1.16

1.63

1.0

1.1

0.94

3.32

u/ml

1.84

108

701

(3028679) Herpes simplex virus Ab [Presence] in Serum

231

1854

1.17

1.62

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

142

1.66

1.58

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

228

1833

1.17

1.57

5.7

6.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

295

1.44

1.54

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

519

5390

0.90

1.49

1.6

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

314

2601

1.14

1.46

2.1

2.2

43.73

38.96

6.92

306

2556

(3000060) B lymphocytes [#/volume] in Blood

123

941

1.23

1.46

1.9

2.2

251.33

572.14

e6/l

0.62

515

(3007733) Chloride [Moles/volume] in Urine

1.94

1.46

1.2

1.6

78.21

88.09

mmol/l

0.35

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.05

1.45

2.5

2.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

347

1.38

1.44

1.0

0.15

1.66

u/ml

0.76

179

(3020618) Glucose [Moles/volume] in Synovial fluid

1.84

1.43

1.1

1.0

7.42

4.91

mmol/l

0.90

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

486

1.32

1.41

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

185

2042

0.85

1.39

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.23

1.38

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

695

1.26

1.38

2.6

80.93

105.05

ng/l

0.90

364

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

310

1.40

1.38

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

122

940

1.22

1.38

1.3

1.2

26.50

19.06

0.43

163

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

250

2054

1.15

1.34

1.6

1.9

4.57

3.46

mg/l

2.82

236

1966

(3012989) Citrate [Moles/time] in 24 hour Urine

1.98

1.33

2.3

1.2

2.08

2.30

mmol/24h

0.21

(3017509) Phencyclidine [Presence] in Urine

402

1.34

1.31

2.3

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

187

1508

1.17

1.30

1.7

2.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.77

1.30

1.1

1.0

0.08

0.07

u/ml

0.04

(3018291) Platelet Ab [Presence] in Serum

2.09

1.27

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

380

1.34

1.27

1.1

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.28

1.26

1.0

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

276

1.40

1.26

1.7

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

259

2146

1.14

1.25

1.1

0.97

4.47

u/ml

1.55

518

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1201

11968

0.94

1.24

2.1

1.9

—

(3022229) Phosphate [Moles/volume] in Urine

160

1.53

1.24

1.8

2.3

16.17

19.90

mmol/l

0.71

137

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

342

1.35

1.22

1.0

0.09

0.46

u/ml

1.27

187

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

573

1.27

1.22

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.05

1.21

1.0

1.1

—

(3049233) Organic acids panel - Urine

2.15

1.20

1.0

1.3

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

147

1.54

1.18

1.2

1.3

1.37

1.68

mg/l

0.74

123

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

304

1.36

1.18

1.3

1.4

12.77

13.78

0.08

158

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.09

1.17

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.09

1.17

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.09

1.17

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.09

1.17

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.09

1.17

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.09

1.17

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

375

3193

1.11

1.16

1.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

122

0.46

1.16

1.0

—

(3014891) Appearance of Pleural fluid

257

1.39

1.16

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

179

1.47

1.14

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

258

2733

0.89

1.14

3.5

3.8

44.06

44.48

u/ml

0.01

251

2712

(3044590) Delta aminolevulinate [Moles/volume] in Urine

2.48

1.13

1.0

1.1

15.00

16.32

umol/l

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

119

1.58

1.12

12.0

15.7

—

(3003338) MCHC [Mass/volume]

27680

259054

1.02

1.10

24.8

15.4

330.18

332.86

g/l

307.65

27497

257240

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1221

12105

0.95

1.09

1.4

—

(3020650) Glucose [Presence] in Urine

108

847

1.20

1.08

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1221

12098

0.95

1.07

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1220

12076

0.95

1.04

1.4

—

(3015183) Erythrocyte sedimentation rate

207

1717

1.14

1.04

1.3

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

199

1.42

1.04

1.0

1.1

16.80

15.56

iu/ml

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1217

12039

0.95

1.02

1.4

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

321

1.32

1.01

1.0

0.02

0.58

u/ml

2.70

183

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

224

1.39

1.01

1.1

21.84

22.50

u/l

0.07

147

(3020356) Listeria sp identified in Specimen by Organism specific culture

265

1.35

0.99

1.3

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

599

1.23

0.99

1.1

0.35

4.24

u/ml

2.73

425

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.98

0.0

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

226

1.37

0.97

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

163

1.44

0.96

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

341

1.30

0.95

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

334

1.30

0.93

1.0

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.65

0.93

1.1

1.0

0.01

0.20

u/ml

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

172

1.42

0.93

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

220

1.37

0.93

2.8

2.7

61.99

52.94

pmol/l

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

212

1.38

0.93

1.6

1.4

27.73

36.98

0.58

139

(3011897) Casein IgE Ab [Units/volume] in Serum

571

1.22

0.91

1.1

1.2

0.21

1.80

u/ml

1.36

564

(3009871) Measles virus Ab [Titer] in Serum

136

1108

1.16

0.91

1.7

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

128

1039

1.16

0.90

1.0

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

134

1.48

0.90

1.0

1.1

-0.94

-3.08

mmol/l

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

104

1.54

0.88

1.0

0.01

0.07

u/ml

—

(40758292) HTLV I+II Ab panel - Serum

498

0.77

0.88

1.2

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

128

1.47

0.85

1.2

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

184

1.38

0.84

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

340

1.27

0.84

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

123

1003

1.15

0.84

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

699

1.19

0.83

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

699

1.19

0.83

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

699

1.19

0.83

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

699

1.19

0.83

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.70

0.82

2.0

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

177

1.38

0.82

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.61

0.81

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

342

1.27

0.81

1.0

4.50

1.57

u/ml

0.28

257

(3006598) pH of Arterial cord blood

138

1.43

0.80

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

147

1220

1.13

0.79

3.2

3.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.67

0.79

2.0

4.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

327

1.27

0.78

2.2

0.86

0.59

u/field

0.94

327

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

255

2189

1.10

0.76

2.4

2.6

837.84

678.69

e6/l

4.55

244

2124

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

2.14

0.75

1.2

1.4

66.76

73.67

nmol/l

—

(3000285) Sodium [Moles/volume] in Blood

296

1.27

0.74

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

205

1.33

0.74

2.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

101

1095

0.87

0.72

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.78

0.72

1.0

164.43

163.00

g/l

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

571

1.19

0.72

1.1

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.60

0.72

1.0

1.1

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.60

0.72

1.7

1.4

69.56

73.07

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

524

0.81

0.71

2.9

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

523

0.81

0.71

5.8

6.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

241

1.29

0.69

1.1

1.0

0.08

0.78

u/ml

3.88

138

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.69

0.69

1.0

0.10

0.13

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.54

0.69

1.3

1.1

3.00

2.42

—

(3047185) IgG [Mass/volume] in Urine

1.59

0.67

1.1

1.0

—

45.20

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

191

0.69

0.66

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

169

1.34

0.65

1.1

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

922

0.87

0.64

1.5

1.8

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

105

1.43

0.64

1.1

1.3

0.73

1.17

u/field

1.23

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.53

0.63

1.0

142.50

386.26

u/l

1.25

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

182

1557

1.10

0.62

1.1

—

(40768795) Lymph node Pathology biopsy report

271

2751

0.93

0.61

1.1

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7892

73381

1.02

0.60

4.4

4.6

2.13

2.89

ug/l

2.59

6967

66503

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.60

0.0

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

139

1.35

0.59

1.1

1.2

0.28

0.75

umol/24h

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

222

1.27

0.59

1.0

0.10

1.96

u/ml

1.84

173

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.43

0.59

1.0

1.1

—

(3022670) pH of Venous cord blood

1.52

0.58

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

283

1.23

0.56

1.1

2.22

1.65

umol/24h

1.84

283

(3010937) Rubella virus Ab [Presence] in Serum

224

1.26

0.56

1.1

—

(3007463) Buprenorphine [Presence] in Urine

149

1.33

0.56

7.3

7.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

361

1.20

0.55

2.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

574

5661

0.95

0.53

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

142

1.33

0.53

1.1

1.2

—

14403.14

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

110

1.37

0.52

5.8

9.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

609

1.14

0.52

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

609

1.14

0.52

1.2

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.49

0.51

2.2

2.3

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.49

0.51

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

127

1.33

0.50

1.4

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

177

1.28

0.50

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1328

12864

0.97

0.50

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

681

0.87

0.49

1.2

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

170

1.27

0.48

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

154

1.28

0.46

1.0

1.7

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

177

0.74

0.46

6.4

5.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

188

1.25

0.46

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

187

0.75

0.45

3.0

5.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

484

1.15

0.45

3.3

2.4

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

240

1.22

0.45

3.3

3.7

1.78

2.23

mg/l

0.72

210

(3044416) Complement C4 [Mass/volume] in Pleural fluid

105

1.34

0.45

1.1

1.2

0.08

g/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

609

1.13

0.44

1.2

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.42

0.42

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

268

1.19

0.42

1.0

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

524

1.13

0.41

4.4

5.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

307

0.83

0.40

1.9

2.5

—

(46235168) Fasting glucose [Moles/volume] in Blood

313

1.17

0.40

1.6

1.9

7.02

7.06

mmol/l

0.02

101

(3045142) Bone marrow Pathology biopsy report

310

2769

1.05

0.40

1.3

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.40

0.0

1.2

—

(3041184) Isoniazid [Presence] in Urine

1.43

0.39

2.0

2.5

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

219

1.20

0.38

2.3

2.5

473.68

406.57

umol/l

0.13

212

(3015076) Soybean IgE Ab [Units/volume] in Serum

222

1968

1.06

0.38

1.0

0.61

0.96

u/ml

0.42

458

(40759632) Porphyrins [Mass/mass] in Stool

1.38

0.38

1.0

1.1

—

(3032641) Amino acids panel - Urine

1.38

0.38

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

185

1.22

0.38

1.0

1.4

—

(3013762) Body weight Measured

109

0.69

0.37

1.0

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.41

0.35

1.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.34

0.34

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

229

2271

0.95

0.33

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

137

1.24

0.32

1.2

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

142

1428

0.94

0.32

5.7

6.0

4386.89

2939.50

u/ml

0.11

282

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

392

1.13

0.32

1.1

1.2

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

146

1.23

0.32

1.8

1.7

0.69

0.71

umol/l

0.07

110

(3022725) Serotonin [Moles/volume] in Serum

104

1.27

0.30

1.2

1.4

676.07

957.01

nmol/l

0.62

(3007542) Rye IgE Ab [Units/volume] in Serum

195

0.82

0.30

1.0

1.1

0.67

10.32

u/ml

0.48

(3020123) Porphyrins [Interpretation] in Serum or Plasma

191

1.18

0.29

1.2

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

143

0.79

0.29

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

396

1.12

0.28

1.9

1.6

—

(3006567) Chloride [Moles/time] in 24 hour Urine

1.30

0.28

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.30

0.28

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.23

0.27

3.0

5.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

326

1.13

0.27

3.1

2.9

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.28

0.26

2.4

2.5

—

(3022475) Manganese [Moles/volume] in Blood

201

0.84

0.25

1.1

1.3

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

346

1.12

0.25

1.0

3.30

1.62

u/ml

0.23

259

(3008536) Aspergillus sp Ab [Presence] in Serum

555

0.92

0.23

1.8

2.4

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.24

0.22

1.4

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.24

0.22

1.4

1.3

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

1.26

0.21

1.0

1.3

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

316

1.10

0.19

1.2

1.4

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

300

1.10

0.18

1.2

1.3

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.75

0.17

1.0

1.4

16.60

65.63

e6/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

193

1.12

0.16

1.0

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

202

0.89

0.16

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.21

0.15

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

168

1631

0.97

0.14

1.0

234.00

334.18

ng/l

3.86

122

1172

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.81

0.13

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

206

1.10

0.12

1.0

11.66

17.84

u/ml

0.59

171

(3008607) Semen analysis panel

143

1.12

0.12

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

143

1.12

0.12

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

170

1642

0.97

0.11

1.0

30.83

42.14

ng/l

5.61

122

1158

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

216

0.92

0.11

1.0

1.1

9.47

7.21

u/ml

0.19

159

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

428

0.95

0.10

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

484

1.05

0.10

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

170

1640

0.98

0.10

1.0

898.02

734.93

ng/l

4.54

120

1138

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

195

0.92

0.09

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.07

0.09

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

435

0.95

0.09

1.2

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

441

1.05

0.08

2.5

2.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

182

1679

1.02

0.08

2.3

2.7

43.60

39.57

2.45

129

914

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.78

0.08

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

164

0.92

0.07

1.0

0.09

9.13

u/ml

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.08

0.07

1.3

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

102

936

1.03

0.07

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

202

0.93

0.07

1.2

1.3

0.14

5.98

u/ml

2.23

170

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.87

0.07

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

555

1.03

0.07

1.4

1.7

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

115

0.90

0.07

2.0

1.3

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

115

0.90

0.07

1.1

1.0

0.23

0.53

u/ml

—

(3013862) HLA-DP [Type]

115

0.90

0.07

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.06

0.07

4.1

3.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

6286

59050

1.00

0.06

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

140

1.08

0.05

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

217

0.95

0.04

1.0

1.1

70.03

28.28

u/ml

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

217

0.95

0.04

1.0

1.1

22.93

22.63

u/ml

—

(46236302) HLA-C [Type] by High resolution typing

112

0.92

0.03

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

112

0.92

0.03

2.2

3.4

—

(40763590) HLA-DQ beta [Type]

112

0.92

0.03

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

112

1042

1.01

0.02

1.1

—

(40760410) HLA-B [Type] by High resolution

111

0.93

0.02

1.0

—

(40760409) HLA-A [Type] by High resolution

111

0.93

0.02

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

224

2122

0.99

0.02

1.4

1.3

129.24

173.72

pmol/l

3.51

224

2122

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

574

0.98

0.02

1.7

1.9

1.92

3.55

ug/l

0.96

346

(4035726) Immunohistochemistry procedure

2548

23957

1.00

0.01

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

299

0.98

0.01

2.8

2.9

2.12

1.21

mg/l

0.65

203

(3003740) Influenza virus B Ag [Presence] in Specimen

582

5490

1.00

0.01

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

251

0.97

0.01

1.0

0.04

0.79

u/ml

1.22

151

(3002523) Influenza virus A Ag [Presence] in Specimen

582

5487

1.00

0.01

1.1

—

(40765096) Chromosome analysis panel by Banding

731

0.99

0.00

1.1

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

182

0.98

0.00

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

111

1.02

0.00

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

170

1.00

0.00

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

119

1.03

0.00

1.1

1.0

0.09

0.31

u/ml

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

108

0.96

0.00

2.2

3.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

108

0.96

0.00

1.5

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

203

1.02

0.00

1.8

2.4

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

0.0

1.2

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.3

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

0.52

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

571.80

—

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.95

-0.00

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.90

-0.00

1.0

1.2

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

3.6

—

140.57

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

10.8

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_NUTRIDEF – Other nutritional deficiencies

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other nutritional deficiencies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other nutritional deficiencies (E4_NUTRIDEF)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints